Հակադեպրեսանտներ (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Հակադեպրեսանտներ" in Armenian language version.

refsWebsite

Global rank Armenian rank

167nih.gov

4^th place

3^rd place

118doi.org

2^nd place

4^th place

34web.archive.org

1^st place

23archive.org

6^th place

17worldcat.org

5^th place

10^th place

10semanticscholar.org

11^th place

428^th place

6fda.gov

447^th place

244^th place

5nice.org.uk

3,258^th place

697^th place

3harvard.edu

18^th place

38^th place

2kcl.ac.uk

3,833^rd place

7,156^th place

2books.google.com

3^rd place

17^th place

2zenodo.org

621^st place

1,041^st place

1europa.eu

68^th place

88^th place

1psychiatryonline.org

4,032^nd place

1,153^rd place

1apotex.com

low place

1handle.net

102^nd place

2,318^th place

1guidelines.gov

low place

1enfa-europe.eu

low place

1cdc.gov

218^th place

51^st place

1webmd.com

1,169^th place

367^th place

1ucsd.edu

1,933^rd place

2,414^th place

1jpharmacol.com

low place

1websitetestlink.com

low place

1wiley.com

222^nd place

187^th place

1medscape.com

719^th place

149^th place

1wyeth.com

low place

1nytimes.com

7^th place

40^th place

1pharmacist.com

low place

1latimes.com

22^nd place

142^nd place

1psychiatrictimes.com

9,815^th place

3,782^nd place

1merckmanuals.com

3,097^th place

347^th place

1vu.edu.au

low place

1time.com

61^st place

179^th place

1cmcsb.com

low place

1aspetjournals.org

6,663^rd place

4,464^th place

1psychosomaticmedicine.org

low place

1aljazeera.com

268^th place

567^th place

1apa.org

1,220^th place

566^th place

1theguardian.com

12^th place

91^st place

1qualitywatch.org.uk

low place

1modernmedicine.com

low place

1gipdatabank.nl

low place

1who.int

195^th place

49^th place

1smith.edu

2,717^th place

7,142^nd place

aljazeera.com

america.aljazeera.com

White, Rebecca. «Waking up from sadness: Many find trouble getting off antidepressants». Al Jazeera. Արխիվացված օրիգինալից 2014 թ․ հուլիսի 14-ին. Վերցված է 2014 թ․ հունիսի 8-ին.

apa.org

«By the numbers: Antidepressant use on the rise». apa.org. Վերցված է 2019 թ․ փետրվարի 1-ին.

apotex.com

«Paroxetine prescribing information» (PDF). Արխիվացված է օրիգինալից (PDF) 2015 թ․ փետրվարի 19-ին. Վերցված է 2015 թ․ հունվարի 30-ին.

archive.org

Kennedy SH, Rizvi S (2009 թ․ ապրիլ). «Sexual dysfunction, depression, and the impact of antidepressants». Journal of Clinical Psychopharmacology. 29 (2): 157–64. doi:10.1097/jcp.0b013e31819c76e9. PMID 19512977.
Byrne SE, Rothschild AJ (1998). «Loss of Antidepressant Efficacy During Maintenance Therapy». The Journal of Clinical Psychiatry. 59 (6): 279–88. doi:10.4088/JCP.v59n0602. PMID 9671339.
Mischoulon D, Nierenberg AA, Kizilbash L, Rosenbaum JF, Fava M (2000). «Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: A survey of clinicians». Canadian Journal of Psychiatry. 45 (5): 476–81. doi:10.1177/070674370004500509. PMID 10900529.
Lam RW, Wan DD, Cohen NL, Kennedy SH (2002). «Combining Antidepressants for Treatment-Resistant Depression». The Journal of Clinical Psychiatry. 63 (8): 685–93. doi:10.4088/JCP.v63n0805. PMID 12197448.
Ross, Lori E.; Grigoriadis, Sophie; Mamisashvili, Lana; VonderPorten, Emily H.; Roerecke, Michael; Rehm, Jürgen; Dennis, Cindy-Lee; Koren, Gideon; Steiner, Meir; Mousmanis, Patricia; Cheung, Amy (2013 թ․ ապրիլի 1). «Selected Pregnancy and Delivery Outcomes After Exposure to Antidepressant Medication». JAMA Psychiatry. 70 (4): 436–43. doi:10.1001/jamapsychiatry.2013.684. PMID 23446732.
Lanza di Scalea T, Wisner KL (2009). «Antidepressant Medication Use During Breastfeeding». Clinical Obstetrics and Gynecology. 52 (3): 483–97. doi:10.1097/GRF.0b013e3181b52bd6. PMC 2902256. PMID 19661763.
Benazzi F (1997). «Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice». J Affect Disord. 46 (1): 73–7. doi:10.1016/S0165-0327(97)00082-7. PMID 9387089.
Grant JE, Potenza MN, eds. (2012). The Oxford handbook of impulse control disorders. Oxford: Oxford University Press. ISBN 978-0-19-538971-5.
Warner, CH; Bobo, W; Warner, C; Reid, S; Rachal, J (2006 թ․ օգոստոսի 1). «Antidepressant discontinuation syndrome». American Family Physician. 74 (3): 449–56. PMID 16913164.
Fournier, JC; DeRubeis, RJ; Hollon, SD; Dimidjian, S; Amsterdam, JD; Shelton, RC; Fawcett, J (2010 թ․ հունվարի 6). «Antidepressant drug effects and depression severity: a patient-level meta-analysis». JAMA. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569.
Gillman PK (2007 թ․ հուլիս). «Tricyclic antidepressant pharmacology and therapeutic drug interactions updated». British Journal of Pharmacology. 151 (6): 737–48. doi:10.1038/sj.bjp.0707253. PMC 2014120. PMID 17471183.
Trindade, E.; Menon, D.; Topfer, L. A.; Coloma, C. (1998 թ․ նոյեմբերի 17). «Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis». Canadian Medical Association Journal. 159 (10): 1245–1252. PMC 1229819. PMID 9861221.
Rothschild R, Quitkin HM, Quitkin FM, Stewart JW, Ocepek-Welikson K, McGrath PJ, և այլք: (1994). «A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives». International Journal of Eating Disorders. 15 (1): 1–9. doi:10.1002/1098-108X(199401)15:1<1::AID-EAT2260150102>3.0.CO;2-E. PMID 8124322.
Taylor D, Carol P, Shitij K (2012). The Maudsley prescribing guidelines in psychiatry. West Sussex: Wiley-Blackwell. ISBN 978-0-470-97969-3.
Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G, Lebowitz B, Shores-Wilson K, Rush AJ (2006). «A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: A STAR*D report». American Journal of Psychiatry. 163 (9): 1519–30. doi:10.1176/appi.ajp.163.9.1519. PMID 16946176.
Kraus MF, Burch EA (1992). «Methylphenidate hydrochloride as an antidepressant: controversy, case studies, and review». South. Med. J. 85 (10): 985–91. doi:10.1097/00007611-199210000-00012. PMID 1411740.
Selikoff IJ, Robitzek EH (1952). «Tuberculosis Chemotherapy with Hydrazine Derivatives of Isonicotinic Acid». Chest. 21 (4): 385–438. doi:10.1378/chest.21.4.385. PMID 14906149.
Healy D (1998). The Psychopharmacologists: Volume 2. A Hodder Arnold Publication. էջեր 132–4. ISBN 978-1-86036-010-7.
Robitzek EH, Selikoff IJ, Mamlok E, Tendlau A (1953). «Isoniazid and Its Isopropyl Derivative in the Therapy of Tuberculosis in Humans: Comparative Therapeutic and Toxicologic Properties». Chest. 23 (1): 1–15. doi:10.1378/chest.23.1.1. PMID 12998444.
López-Muñoz F, Alamo C, Juckel G, Assion HJ (2007). «Half a Century of Antidepressant Drugs». Journal of Clinical Psychopharmacology. 27 (6): 555–9. doi:10.1097/jcp.0b013e3181bb617. PMID 18004120.
Kuhn R (1958). «The treatment of depressive states with G 22355 (imipramine hydrochloride)». The American Journal of Psychiatry. 115 (5): 459–64. doi:10.1176/ajp.115.5.459. PMID 13583250.
Lock M, Nguyen VK (2010). «"Local Biologies and Human Difference». An anthropology of biomedicine (1st ed.). Chichester, West Sussex: Wiley-Blackwell. էջեր 83–109. ISBN 978-1-4051-1071-6.
Winberg S, Carter CG, McCarthy JD, He XY, Nilsson GE, Houlihan DF (1993). «Feeding rank and brain serotonergic activity in rainbow trout Onchorhynchus my kiss». J. Exp. Biol. 179: 197–211.

aspetjournals.org

jpet.aspetjournals.org

Wong DT, Bymaster FP, Horng JS, Molloy BB (1975). «A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine». The Journal of Pharmacology and Experimental Therapeutics. 193 (3): 804–11. PMID 1151730. Արխիվացված է օրիգինալից 2021 թ․ նոյեմբերի 19-ին. Վերցված է 2020 թ․ հունվարի 30-ին.

books.google.com

Preskorn SH, Ross R, Stanga CY (2004). «Selective Serotonin Reuptake Inhibitors». In Sheldon H. Preskorn, Hohn P. Feighner, Christina Y. Stanga, Ruth Ross (eds.). Antidepressants: Past, Present and Future. Berlin: Springer. էջեր 241–62. ISBN 978-3-540-43054-4.
Healy D (2001). «The Antidepressant Drama». In Weissman M (ed.). The treatment of depression: bridging the 21st century. American Psychiatric Pub. էջեր 10–11. ISBN 978-0-88048-397-1. Վերցված է 2009 թ․ մայիսի 28-ին.

cdc.gov

«Antidepressant Use in Persons Aged 12 and Over: United States, 2005–2008». cdc.gov. Products – Data Briefs – Number 76 – October 2011. Centers for Disease Control and Prevention. Արխիվացված օրիգինալից 2016 թ․ փետրվարի 4-ին. Վերցված է 2016 թ․ փետրվարի 4-ին.

cmcsb.com

«Tranquilizers». Cumberland Mountain Community Services. cmcsb.com. Արխիվացված է օրիգինալից 2012 թ․ սեպտեմբերի 16-ին. Վերցված է 2013 թ․ նոյեմբերի 20-ին.Կաղապար:Unreliable medical source

doi.org

Jennings, Leigh (2018). «Chapter 4: Antidepressants». In Grossberg, George T.; Kinsella, Laurence J. (eds.). Clinical psychopharmacology for neurologists: a practical guide. Springer. էջեր 45–71. doi:10.1007/978-3-319-74604-3_4. ISBN 978-3-319-74602-9.
Healy D, Noury LJ, Manginb D (2018 թ․ մայիս). «Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases». International Journal of Risk & Safety in Medicine. 29 (3): 125–134. doi:10.3233/JRS-180744. PMC 6004900. PMID 29733030.
Taylor MJ, Rudkin L, Bullemor-Day P, Lubin J, Chukwujekwu C, Hawton K (2013 թ․ մայիս). «Strategies for managing sexual dysfunction induced by antidepressant medication». The Cochrane Database of Systematic Reviews. 5 (5): CD003382. doi:10.1002/14651858.CD003382.pub3. PMID 23728643.
Bahrick AS (2008). «Persistence of Sexual Dysfunction Side Effects after Discontinuation of Antidepressant Medications: Emerging Evidence». The Open Psychology Journal. 1: 42–50. doi:10.2174/1874350100801010042.
Kennedy SH, Rizvi S (2009 թ․ ապրիլ). «Sexual dysfunction, depression, and the impact of antidepressants». Journal of Clinical Psychopharmacology. 29 (2): 157–64. doi:10.1097/jcp.0b013e31819c76e9. PMID 19512977.
Wilson, E; Lader, M (2015 թ․ դեկտեմբեր). «A review of the management of antidepressant discontinuation symptoms». Therapeutic Advances in Psychopharmacology. 5 (6): 357–68. doi:10.1177/2045125315612334. PMC 4722507. PMID 26834969.
Gabriel, M; Sharma, V (2017 թ․ մայիսի 29). «Antidepressant discontinuation syndrome». Canadian Medical Association Journal. 189 (21): E747. doi:10.1503/cmaj.160991. PMC 5449237. PMID 28554948.
Cipriani, Andrea; Furukawa, Toshi A; Salanti, Georgia; Chaimani, Anna; Atkinson, Lauren Z; Ogawa, Yusuke; Leucht, Stefan; Ruhe, Henricus G; Turner, Erick H; Higgins, Julian P T; Egger, Matthias; Takeshima, Nozomi; Hayasaka, Yu; Imai, Hissei; Shinohara, Kiyomi; Tajika, Aran; Ioannidis, John P A; Geddes, John R (2018). «Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». The Lancet. 391 (10128): 1357–1366. doi:10.1016/S0140-6736(17)32802-7. ISSN 0140-6736. PMC 5889788. PMID 29477251.
Barth, Michael; Kriston, Levente; Klostermann, Swaantje; Barbui, Corrado; Cipriani, Andrea; Linde, Klaus (2018). «Efficacy of selective serotonin reuptake inhibitors and adverse events: Meta-regression and mediation analysis of placebo-controlled trials». British Journal of Psychiatry. 208 (2): 114–119. doi:10.1192/bjp.bp.114.150136. ISSN 0007-1250. PMID 26834168.
Jakobsen, JC; Gluud, C; Kirsch, I (2019 թ․ սեպտեմբերի 25). «Should antidepressants be used for major depressive disorder?». BMJ Evidence-based Medicine: bmjebm–2019–111238. doi:10.1136/bmjebm-2019-111238. PMID 31554608.
Cipriani, Andrea; Zhou, Xinyu; Del Giovane, Cinzia; Hetrick, Sarah E; Qin, Bin; Whittington, Craig; Coghill, David; Zhang, Yuqing; Hazell, Philip; Leucht, Stefan; Cuijpers, Pim; Pu, Juncai; Cohen, David; Ravindran, Arun V; Liu, Yiyun; Michael, Kurt D; Yang, Lining; Liu, Lanxiang; Xie, Peng (2016). «Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis». The Lancet. 388 (10047): 881–890. doi:10.1016/S0140-6736(16)30385-3. ISSN 0140-6736. PMID 27289172. «When considering the risk-benefit profile of antidepressants in the acute treatment of major depressive disorder, these drugs do not seem to offer a clear advantage for children and adolescents.»
Turner, Erick H; Rosenthal, Robert (2008). «Efficacy of antidepressants». BMJ. 336 (7643): 516–517. doi:10.1136/bmj.39510.531597.80. ISSN 0959-8138. PMC 2265347. PMID 18319297.
Kirsch, Irving (2014). «Antidepressants and the Placebo Effect». Zeitschrift für Psychologie. 222 (3): 128–134. doi:10.1027/2151-2604/a000176. ISSN 2190-8370. PMC 4172306. PMID 25279271.
Hansen, Richard A.; Gaynes, Bradley N.; Gartlehner, Gerald; Moore, Charity G.; Tiwari, Ruchi; Lohr, Kathleen N. (2008 թ․ մայիս). «Efficacy and Tolerability of Second-Generation Antidepressants in Social Anxiety Disorder». International Clinical Psychopharmacology. 23 (3): 170–179. doi:10.1097/YIC.0b013e3282f4224a. ISSN 0268-1315. PMC 2657552. PMID 18408531.
Canton, John; Scott, Kate M; Glue, Paul (2012). «Optimal treatment of social phobia: systematic review and meta-analysis». Neuropsychiatric Disease and Treatment. 8: 203–215. doi:10.2147/NDT.S23317. ISSN 1176-6328. PMC 3363138. PMID 22665997.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Soomro, GM; Altman, D; Rajagopal, S; Oakley-Browne, M (2008 թ․ հունվարի 23). «Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)». The Cochrane Database of Systematic Reviews (1): CD001765. doi:10.1002/14651858.CD001765.pub3. PMID 18253995.
Fineberg, N. A.; Brown, A; Reghunandanan, S; Pampaloni, I (2012). «Evidence-based pharmacotherapy of obsessive-compulsive disorder». The International Journal of Neuropsychopharmacology. 15 (8): 1173–91. doi:10.1017/S1461145711001829. hdl:2299/216. PMID 22226028.
Bighelli, Irene; Castellazzi, Mariasole; Cipriani, Andrea; Girlanda, Francesca; Guaiana, Giuseppe; Koesters, Markus; Turrini, Giulia; Furukawa, Toshi A.; Barbui, Corrado (2018 թ․ ապրիլի 5). «Antidepressants versus placebo for panic disorder in adults». The Cochrane Database of Systematic Reviews. 4: CD010676. doi:10.1002/14651858.CD010676.pub2. ISSN 1469-493X. PMC 6494573. PMID 29620793.
Andrisano, Costanza; Chiesa, Alberto; Serretti, Alessandro (2013 թ․ հունվար). «Newer antidepressants and panic disorder: a meta-analysis». International Clinical Psychopharmacology. 28 (1): 33–45. doi:10.1097/YIC.0b013e32835a5d2e. ISSN 1473-5857. PMID 23111544.
Bighelli, Irene; Trespidi, Carlotta; Castellazzi, Mariasole; Cipriani, Andrea; Furukawa, Toshi A.; Girlanda, Francesca; Guaiana, Giuseppe; Koesters, Markus; Barbui, Corrado (2016 թ․ սեպտեմբերի 12). «Antidepressants and benzodiazepines for panic disorder in adults». The Cochrane Database of Systematic Reviews. 9: CD011567. doi:10.1002/14651858.CD011567.pub2. ISSN 1469-493X. PMC 6457579. PMID 27618521.
Flament MF, Bissada H, Spettigue W (2012 թ․ մարտ). «Evidence-based pharmacotherapy of eating disorders». Int. J. Neuropsychopharmacol. 15 (2): 189–207. doi:10.1017/S1461145711000381. PMID 21414249.
Häuser W, Wolfe F, Tölle T, Uçeyler N, Sommer C (2012 թ․ ապրիլ). «The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis». CNS Drugs. 26 (4): 297–307. doi:10.2165/11598970-000000000-00000. PMID 22452526.
Lunn MP, Hughes RA, Wiffen PJ (2014). «Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia». Cochrane Database Syst Rev. 1 (1): CD007115. doi:10.1002/14651858.CD007115.pub3. PMID 24385423.
Moore, R. Andrew; Derry, Sheena; Aldington, Dominic; Cole, Peter; Wiffen, Philip J. (2015 թ․ հուլիսի 6). «Amitriptyline for neuropathic pain in adults». The Cochrane Database of Systematic Reviews (7): CD008242. doi:10.1002/14651858.CD008242.pub3. ISSN 1469-493X. PMC 6447238. PMID 26146793.
Agabio, Roberta; Trogu, Emanuela; Pani, Pier Paolo (2018). «Antidepressants for the treatment of people with co-occurring depression and alcohol dependence». The Cochrane Database of Systematic Reviews. 4: CD008581. doi:10.1002/14651858.CD008581.pub2. ISSN 1469-493X. PMC 6494437. PMID 29688573.
Richards, Bethan L; Whittle, Samuel L; Buchbinder, Rachelle (2011 թ․ նոյեմբերի 9). «Antidepressants for pain management in rheumatoid arthritis». Cochrane Database of Systematic Reviews (11): CD008920. doi:10.1002/14651858.cd008920.pub2. ISSN 1465-1858. PMID 22071859.
Baghai TC, Möller HJ, Rupprecht R (2006). «Recent Progress in Pharmacological and Non-Pharmacological Treatment Options of Major Depression». Current Pharmaceutical Design. 12 (4): 503–15. doi:10.2174/138161206775474422. PMID 16472142.
Ruhé HG, Huyser J, Swinkels JA, Schene AH (2006). «Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder». The Journal of Clinical Psychiatry. 67 (12): 1836–55. doi:10.4088/JCP.v67n1203. PMID 17194261.
Byrne SE, Rothschild AJ (1998). «Loss of Antidepressant Efficacy During Maintenance Therapy». The Journal of Clinical Psychiatry. 59 (6): 279–88. doi:10.4088/JCP.v59n0602. PMID 9671339.
Mischoulon D, Nierenberg AA, Kizilbash L, Rosenbaum JF, Fava M (2000). «Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: A survey of clinicians». Canadian Journal of Psychiatry. 45 (5): 476–81. doi:10.1177/070674370004500509. PMID 10900529.
DeBattista C, Lembke A (2005). «Update on augmentation of antidepressant response in resistant depression». Current Psychiatry Reports. 7 (6): 435–40. doi:10.1007/s11920-005-0064-x. PMID 16318821.
Lam RW, Wan DD, Cohen NL, Kennedy SH (2002). «Combining Antidepressants for Treatment-Resistant Depression». The Journal of Clinical Psychiatry. 63 (8): 685–93. doi:10.4088/JCP.v63n0805. PMID 12197448.
Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH (2013). «Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials». The Journal of Clinical Psychiatry. 74 (11): 1101–7. doi:10.4088/JCP.13r08560. PMID 24330897.
Boyer EW, Shannon M (2005). «The serotonin syndrome» (PDF). N. Engl. J. Med. 352 (11): 1112–20. doi:10.1056/NEJMra041867. PMID 15784664. Արխիվացված է օրիգինալից (PDF) 2013 թ․ հունիսի 18-ին.
Mason PJ, Morris VA, Balcezak TJ (2000). «Serotonin syndrome. Presentation of 2 cases and review of the literature». Medicine. 79 (4): 201–9. doi:10.1097/00005792-200007000-00001. PMID 10941349.
Salvi, Virginio; Grua, Ilaria; Cerveri, Giancarlo; Mencacci, Claudio; Barone-Adesi, Francesco (2017 թ․ հուլիսի 31). Meyre, David (ed.). Կաղապար:CC-PMC. «The risk of new-onset diabetes in antidepressant users – A systematic review and meta-analysis». PLOS ONE. Public Library of Science (PLoS). 12 (7): e0182088. Bibcode:2017PLoSO..1282088S. doi:10.1371/journal.pone.0182088. ISSN 1932-6203. PMC 5536271. PMID 28759599. «In our meta-analysis we found an association between exposure to ADs and new-onset diabetes, with a relative risk of 1.27. When we restricted the analysis to the studies to high NOS score the association between ADs and diabetes was even stronger. The results are in line with those from two previous meta-analyses that reported a 1.5-fold increase of diabetes among AD users.»{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Sathyanarayana Rao TS, Yeragani VK (2009). «Hypertensive crisis and cheese». Indian J Psychiatry. 51 (1): 65–6. doi:10.4103/0019-5545.44910. PMC 2738414. PMID 19742203.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Paykel ES (1995). «Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression». Acta Psychiatr Scand Suppl. 386: 22–7. doi:10.1111/j.1600-0447.1995.tb05920.x. PMID 7717091.
Malm H (2012 թ․ դեկտեմբեր). «Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome». Ther Drug Monit. 34 (6): 607–14. doi:10.1097/FTD.0b013e31826d07ea. PMID 23042258.
Rahimi R, Nikfar S, Abdollahi M (2006). «Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials». Reproductive Toxicology. 22 (4): 571–575. doi:10.1016/j.reprotox.2006.03.019. PMID 16720091.
Nikfar S, Rahimi R, Hendoiee N, Abdollahi M (2012). «Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis». Daru. 20 (1): 75. doi:10.1186/2008-2231-20-75. PMC 3556001. PMID 23351929.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Huang H, Coleman S, Bridge JA, Yonkers K, Katon W (2014). «A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight». General Hospital Psychiatry. 36 (1): 13–8. doi:10.1016/j.genhosppsych.2013.08.002. PMC 3877723. PMID 24094568.
Riggin L, Frankel Z, Moretti M, Pupco A, Koren G (2013 թ․ ապրիլ). «The fetal safety of fluoxetine: a systematic review and meta-analysis». J Obstet Gynaecol Can. 35 (4): 362–9. doi:10.1016/S1701-2163(15)30965-8. PMID 23660045.
Koren G, Nordeng HM (2013 թ․ փետրվար). «Selective serotonin reuptake inhibitors and malformations: case closed?». Semin Fetal Neonatal Med. 18 (1): 19–22. doi:10.1016/j.siny.2012.10.004. PMID 23228547.
Ross, Lori E.; Grigoriadis, Sophie; Mamisashvili, Lana; VonderPorten, Emily H.; Roerecke, Michael; Rehm, Jürgen; Dennis, Cindy-Lee; Koren, Gideon; Steiner, Meir; Mousmanis, Patricia; Cheung, Amy (2013 թ․ ապրիլի 1). «Selected Pregnancy and Delivery Outcomes After Exposure to Antidepressant Medication». JAMA Psychiatry. 70 (4): 436–43. doi:10.1001/jamapsychiatry.2013.684. PMID 23446732.
Lanza di Scalea T, Wisner KL (2009). «Antidepressant Medication Use During Breastfeeding». Clinical Obstetrics and Gynecology. 52 (3): 483–97. doi:10.1097/GRF.0b013e3181b52bd6. PMC 2902256. PMID 19661763.
Goldberg JF, Truman CJ (2003). «Antidepressant-induced mania: An overview of current controversies». Bipolar Disorders. 5 (6): 407–20. doi:10.1046/j.1399-5618.2003.00067.x. PMID 14636364.
Benazzi F (1997). «Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice». J Affect Disord. 46 (1): 73–7. doi:10.1016/S0165-0327(97)00082-7. PMID 9387089.
Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G (2009). «Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration». BMJ. 339: b2880. doi:10.1136/bmj.b2880. PMC 2725270. PMID 19671933.
Friedman RA, Leon AC (2007). «Expanding the black box – depression, antidepressants, and the risk of suicide». N. Engl. J. Med. 356 (23): 2343–6. doi:10.1056/NEJMp078015. PMID 17485726.
Healy D, Aldred G (2005). «Antidepressant drug use and the risk of suicide» (PDF). International Review of Psychiatry. 17 (3): 163–172. doi:10.1080/09540260500071624. PMID 16194787. Արխիվացված է օրիգինալից (PDF) 2013 թ․ հոկտեմբերի 21-ին.
Healy, David; Le Noury, Joanna; Mangin, Derelie (2018 թ․ հունիսի 4). «Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases». International Journal of Risk & Safety in Medicine. 29 (3–4): 125–134. doi:10.3233/JRS-180744. PMC 6004900. PMID 29733030.
Csoka AB, Csoka A, Bahrick A, Mehtonen OP (2008). «Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors». J Sex Med. 5 (1): 227–33. doi:10.1111/j.1743-6109.2007.00630.x. PMID 18173768.
Serretti A, Chiesa A (2009). «Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis». J Clin Psychopharmacol. 29 (3): 259–66. doi:10.1097/JCP.0b013e3181a5233f. PMID 19440080.
Keltner NL, McAfee KM, Taylor CL (2009). «Biological Perspectives». Perspectives in Psychiatric Care. 38 (3): 111–6. doi:10.1111/j.1744-6163.2002.tb00665.x. PMID 12385082.
Ozmenler NK, Karlidere T, Bozkurt A, Yetkin S, Doruk A, Sutcigil L, Cansever A, Uzun O, Ozgen F, Ozsahin A (2008). «Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors». Hum Psychopharmacol. 23 (4): 321–6. doi:10.1002/hup.929. PMID 18278806.
Schwasinger-Schmidt, TE; Macaluso, M (2018 թ․ սեպտեմբերի 8). «Other Antidepressants». Handbook of Experimental Pharmacology. 250: 325–355. doi:10.1007/164_2018_167. ISBN 978-3-030-10948-6. PMID 30194544.
Stimmel GL, Dopheide JA, Stahl SM (1997). «Mirtazapine: An antidepressant with noradrenergic and specific serotonergic effects». Pharmacotherapy. 17 (1): 10–21. doi:10.1002/j.1875-9114.1997.tb03674.x (inactive 2020 թ․ հունվարի 16). PMID 9017762. Արխիվացված է օրիգինալից 2021 թ․ մայիսի 25-ին. Վերցված է 2020 թ․ հունվարի 28-ին.{{cite journal}}: CS1 սպաս․ DOI inactive as of 2020 (link)
Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR, Hilton L, Suttorp M, Solomon V, Shekelle PG, Morton SC (2005 թ․ ապրիլ). «Meta-analysis: pharmacologic treatment of obesity». Ann. Intern. Med. 142 (7): 532–46. doi:10.7326/0003-4819-142-7-200504050-00012. PMID 15809465.
Davies, J; Read, J (2018 թ․ սեպտեմբերի 4). «A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?». Addictive Behaviors. 97: 111–121. doi:10.1016/j.addbeh.2018.08.027. PMID 30292574.
Pringle, A; McCabe, C; Cowen, PJ; Harmer, CJ (2013 թ․ օգոստոս). «Antidepressant treatment and emotional processing: can we dissociate the roles of serotonin and noradrenaline?». Journal of Psychopharmacology (Oxford, England). 27 (8): 719–31. doi:10.1177/0269881112474523. PMID 23392757.
Fornaro, M; Anastasia, A; Novello, S; Fusco, A; Pariano, R; De Berardis, D; Solmi, M; Veronese, N; Stubbs, B; Vieta, E; Berk, M; de Bartolomeis, A; Carvalho, AF (2018 թ․ հոկտեմբերի 29). «The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications». Pharmacological Research. 139: 494–502. doi:10.1016/j.phrs.2018.10.025. PMID 30385364.
Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, Kubera M, Bob P, Lerer B, Maj M (2009 թ․ մարտ). «The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression». Metabolic Brain Disease. 24 (1): 27–53. doi:10.1007/s11011-008-9118-1. PMID 19085093.
Sanacora G, Treccani G, Popoli M (2012 թ․ հունվար). «Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders». Neuropharmacology. 62 (1): 63–77. doi:10.1016/j.neuropharm.2011.07.036. PMC 3205453. PMID 21827775.
Menke A, Klengel T, Binder EB (2012). «Epigenetics, depression and antidepressant treatment». Current Pharmaceutical Design. 18 (36): 5879–5889. doi:10.2174/138161212803523590. PMID 22681167.
Vialou V, Feng J, Robison AJ, Nestler EJ (2013 թ․ հունվար). «Epigenetic mechanisms of depression and antidepressant action». Annual Review of Pharmacology and Toxicology. 53 (1): 59–87. doi:10.1146/annurev-pharmtox-010611-134540. PMC 3711377. PMID 23020296.
Pies R (2010 թ․ ապրիլ). «Antidepressants Work, Sort of-Our System of Care Does Not». Journal of Clinical Psychopharmacology. 30 (2): 101–104. doi:10.1097/JCP.0b013e3181d52dea. PMID 20520282.
Fournier, JC; DeRubeis, RJ; Hollon, SD; Dimidjian, S; Amsterdam, JD; Shelton, RC; Fawcett, J (2010 թ․ հունվարի 6). «Antidepressant drug effects and depression severity: a patient-level meta-analysis». JAMA. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569.
Pies, Ronald W. (2016). «Antidepressants». Journal of Clinical Psychopharmacology. 36 (1): 1–4. doi:10.1097/jcp.0000000000000455. PMID 26658086.
Cashman, JR; Ghirmai, S (2009). «Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression». Bioorganic & Medicinal Chemistry. 17 (19): 6890–7. doi:10.1016/j.bmc.2009.08.025. PMID 19740668.
Hughes ZA, Starr KR, Langmead CJ, և այլք: (2005 թ․ մարտ). «Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone». European Journal of Pharmacology. 510 (1–2): 49–57. doi:10.1016/j.ejphar.2005.01.018. PMID 15740724.
Gasior M, Bergman J, Kallman MJ, Paronis CA (2005 թ․ ապրիլ). «Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys». Neuropsychopharmacology. 30 (4): 758–64. doi:10.1038/sj.npp.1300593. PMID 15526000.
Wee S, Woolverton WL (2004 թ․ սեպտեմբեր). «Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine». Drug and Alcohol Dependence. 75 (3): 271–6. doi:10.1016/j.drugalcdep.2004.03.010. PMID 15283948.
Rothman RB, Baumann MH, Dersch CM, և այլք: (2001 թ․ հունվար). «Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin». Synapse. 39 (1): 32–41. doi:10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3. PMID 11071707.
Tatsumi M, Groshan K, Blakely RD, Richelson E (1997). «Pharmacological profile of antidepressants and related compounds at human monoamine transporters». Eur J Pharmacol. 340 (2–3): 249–258. doi:10.1016/S0014-2999(97)01393-9. PMID 9537821.
Gillman PK (2007 թ․ հուլիս). «Tricyclic antidepressant pharmacology and therapeutic drug interactions updated». British Journal of Pharmacology. 151 (6): 737–48. doi:10.1038/sj.bjp.0707253. PMC 2014120. PMID 17471183.
Liebowitz, MR; Schneier, FR; Campeas, R; Hollander, E; Hatterer, J; Fyer, A; և այլք: (1992). «Phenelzine vs atenolol in social phobia: A placebo-controlled comparison». Archives of General Psychiatry. 49 (4): 290–300. doi:10.1001/archpsyc.49.4.290. PMID 1558463.
Versiani M, Nardi AE, Mundim FD, Alves AB, Liebowitz MR, Amrein R. Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine. BJP [Internet]. 1992 Sep 1 [cited 2013 Oct 4];161(3):353–60. Available from: Versiani, M.; Nardi, A. E.; Mundim, F. D.; Alves, A. B.; Liebowitz, M. R.; Amrein, R. (1992). «Pharmacotherapy of Social Phobia». British Journal of Psychiatry. 161 (3): 353–360. doi:10.1192/bjp.161.3.353. PMID 1393304.
Heimberg, RG; Liebowitz, MR; Hope, DA; և այլք: (1998). «Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome». Arch Gen Psychiatry. 55 (12): 1133–41. doi:10.1001/archpsyc.55.12.1133. PMID 9862558.
Jarrett, RB; Schaffer, M; McIntire, D; Witt-Browder, A; Kraft, D; Risser, RC (1999). «Treatment of atypical depression with cognitive therapy or phenelzine: A double-blind, placebo-controlled trial». Arch Gen Psychiatry. 56 (5): 431–7. doi:10.1001/archpsyc.56.5.431. PMC 1475805. PMID 10232298.
Liebowitz, MR; Quitkin, FM; Stewart, JW; և այլք: (1984). «Phenelzine v imipramine in atypical depression: A preliminary report». Arch Gen Psychiatry. 41 (7): 669–77. doi:10.1001/archpsyc.1984.01790180039005. PMID 6375621.
Walsh, B; Stewart, JW; Roose, SP; Gladis, M; Glassman, AH (1984). «Treatment of bulimia with phenelzine: A double-blind, placebo-controlled study». Arch Gen Psychiatry. 41 (11): 1105–9. doi:10.1001/archpsyc.1983.01790220095015. PMID 6388524.
Rothschild R, Quitkin HM, Quitkin FM, Stewart JW, Ocepek-Welikson K, McGrath PJ, և այլք: (1994). «A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives». International Journal of Eating Disorders. 15 (1): 1–9. doi:10.1002/1098-108X(199401)15:1<1::AID-EAT2260150102>3.0.CO;2-E. PMID 8124322.
Walsh, BT; Stewart, JW; Roose, SP; Gladis, M; Glassman, AH (1985). «A double-blind trial of phenelzine in bulimia». Journal of Psychiatric Research. 19 (2–3): 485–9. doi:10.1016/0022-3956(85)90058-5. PMID 3900362.
Walsh, B; Gladis, M; Roose, SP; Stewart, JW; Stetner, F; Glassman, AH (1988 թ․ մայիս). «Phenelzine vs placebo in 50 patients with bulimia». Arch Gen Psychiatry. 45 (5): 471–5. doi:10.1001/archpsyc.1988.01800290091011. PMID 3282482.
Davidson, J; Ingram, J; Kilts, C (1987). «A pilot study of phenelzine in the treatment of post-traumatic stress disorder». The British Journal of Psychiatry. 150 (2): 252–5. doi:10.1192/bjp.150.2.252. PMID 3651684.
Soloff, PH; Cornelius, J; George, A; Nathan, S; Perel, JM; Ulrich, RF (1993). «Efficacy of phenelzine and haloperidol in borderline personality disorder». Arch Gen Psychiatry. 50 (5): 377–85. doi:10.1001/archpsyc.1993.01820170055007. PMID 8489326.
Liebowitz, MR; Hollander, E; Schneier, F; Campeas, R; Welkowitz, L; Hatterer, J; Fallon, B (1990). «Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders». Acta Psychiatr Scand Suppl. 360: 29–34. doi:10.1111/j.1600-0447.1990.tb05321.x. PMID 2248064.
Cox, Georgina R.; Callahan, Patch; Churchill, Rachel; Hunot, Vivien; Merry, Sally N.; Parker, Alexandra G.; Hetrick, Sarah E. (2014 թ․ նոյեմբերի 30). «Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents» (PDF). The Cochrane Database of Systematic Reviews. 11 (11): CD008324. doi:10.1002/14651858.CD008324.pub3. ISSN 1469-493X. PMID 25433518.
Bauer M, Dopfmer S (1999). «Lithium augmentation in treatment-resistant depression: Meta-analysis of placebo-controlled studies». Journal of Clinical Psychopharmacology. 19 (5): 427–34. doi:10.1097/00004714-199910000-00006. PMID 10505584.
Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ (2007 թ․ մարտ). «Lithium treatment reduces suicide risk in recurrent major depressive disorder». J Clin Psychiatry. 68 (3): 380–83. doi:10.4088/JCP.v68n0304. PMID 17388706.
Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G, Lebowitz B, Shores-Wilson K, Rush AJ (2006). «A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: A STAR*D report». American Journal of Psychiatry. 163 (9): 1519–30. doi:10.1176/appi.ajp.163.9.1519. PMID 16946176.
Kraus MF, Burch EA (1992). «Methylphenidate hydrochloride as an antidepressant: controversy, case studies, and review». South. Med. J. 85 (10): 985–91. doi:10.1097/00007611-199210000-00012. PMID 1411740.
Orr, K; Taylor, D (2007). «Psychostimulants in the treatment of depression : a review of the evidence». CNS Drugs. 21 (3): 239–57. doi:10.2165/00023210-200721030-00004. PMID 17338594.
Heal DJ, Smith SL, Gosden J, Nutt DJ (2013 թ․ հունիս). «Amphetamine, past and present – a pharmacological and clinical perspective». J. Psychopharmacol. 27 (6): 479–96. doi:10.1177/0269881113482532. PMC 3666194. PMID 23539642.
Weber MM, Emrich HM (1988). «Current and Historical Concepts of Opiate Treatment in Psychiatric Disorders». International Clinical Psychopharmacology. 3 (3): 255–66. doi:10.1097/00004850-198807000-00007. PMID 3153713.
Czygan FC (2003). «Kulturgeschichte und Mystik des Johanniskrauts: Vom 2500 Jahre alten Apotropaikum zum aktuellen Antidepressivum» [From a 2500-year-old apotropic comes a current antidepressive. The cultural history and mistique of St. John's wort]. Pharmazie in Unserer Zeit (German). 32 (3): 184–90. doi:10.1002/pauz.200390062. PMID 12784538.{{cite journal}}: CS1 սպաս․ չճանաչված լեզու (link)
Selikoff IJ, Robitzek EH (1952). «Tuberculosis Chemotherapy with Hydrazine Derivatives of Isonicotinic Acid». Chest. 21 (4): 385–438. doi:10.1378/chest.21.4.385. PMID 14906149.
Robitzek EH, Selikoff IJ, Mamlok E, Tendlau A (1953). «Isoniazid and Its Isopropyl Derivative in the Therapy of Tuberculosis in Humans: Comparative Therapeutic and Toxicologic Properties». Chest. 23 (1): 1–15. doi:10.1378/chest.23.1.1. PMID 12998444.
López-Muñoz F, Alamo C, Juckel G, Assion HJ (2007). «Half a Century of Antidepressant Drugs». Journal of Clinical Psychopharmacology. 27 (6): 555–9. doi:10.1097/jcp.0b013e3181bb617. PMID 18004120.
Kuhn R (1958). «The treatment of depressive states with G 22355 (imipramine hydrochloride)». The American Journal of Psychiatry. 115 (5): 459–64. doi:10.1176/ajp.115.5.459. PMID 13583250.
Healy D (1999). «The Three Faces of the Antidepressants: A Critical Commentary on the Clinical-Economic Context of Diagnosis». The Journal of Nervous & Mental Disease. 187 (3): 174–80. doi:10.1097/00005053-199903000-00007. PMID 10086474.
Pletscher A (1991). «The discovery of antidepressants: A winding path». Experientia. 47 (1): 4–8. doi:10.1007/BF02041242. PMID 1999242.
Domino EF (1999). «History of modern psychopharmacology: A personal view with an emphasis on antidepressants». Psychosomatic Medicine. 61 (5): 591–8. doi:10.1097/00006842-199909000-00002. PMID 10511010.
Freeman, H (1996). «Tolerability and safety of novel antidepressants». European Psychiatry. 11: 206s. doi:10.1016/0924-9338(96)88597-X.
Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D (1996). «St John's wort for depression—an overview and meta-analysis of randomised clinical trials». BMJ. 313 (7052): 253–8. doi:10.1136/bmj.313.7052.253. PMC 2351679. PMID 8704532.
Müller WE (2003). «Current St. John's wort research from mode of action to clinical efficacy». Pharmacological Research. 47 (2): 101–9. doi:10.1016/S1043-6618(02)00266-9. PMID 12543057.
Nathan PJ (2001). «Hypericum perforatum (St John's Wort): A non-selective reuptake inhibitor? A review of the recent advances in its pharmacology». Journal of Psychopharmacology. 15 (1): 47–54. doi:10.1177/026988110101500109. PMID 11277608.
Kaplan, Jessica E.; Keeley, Robert D.; Engel, Matthew; Emsermann, Caroline; Brody, David (2013 թ․ հուլիս). «Aspects of patient and clinician language predict adherence to antidepressant medication». Journal of the American Board of Family Medicine: JABFM. 26 (4): 409–420. doi:10.3122/jabfm.2013.04.120201. PMID 23833156.
Ho, SC; Chong, HY; Chaiyakunapruk, N; Tangiisuran, B; Jacob, SA (2016 թ․ մարտի 15). «Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: A systematic review». Journal of Affective Disorders. 193: 1–10. doi:10.1016/j.jad.2015.12.029. PMID 26748881.
Ecks S (2005). «Pharmaceutical Citizenship: Antidepressant Marketing and the Promise of Demarginalization in India». Anthropology & Medicine. 12 (3): 239–254. doi:10.1080/13648470500291360. PMID 26873669.
Zhou Z, Zhen J, Karpowich NK, Goetz RM, Law CJ, Reith ME, Wang DN (2007). «LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake». Science. 317 (5843): 1390–3. Bibcode:2007Sci...317.1390Z. doi:10.1126/science.1147614. PMC 3711652. PMID 17690258.
Brooks BW, Chambliss CK, Stanley JK, Ramirez A, Banks KE, Johnson RD, Lewis RJ (2005). «Determination of select antidepressants in fish from an effluent-dominated stream». Environ. Toxicol. Chem. 24 (2): 464–9. doi:10.1897/04-081r.1. PMID 15720009.
Fent K, Weston AA, Caminada D (2006). «Ecotoxicology of human pharmaceuticals». Aquat. Toxicol. 76 (2): 122–59. doi:10.1016/j.aquatox.2005.09.009. PMID 16257063.
Huber R, Smith K, Delago A, Isaksson K, Kravitz EA (1997). «Serotonin and aggressive motivation in crustaceans: altering the decision to retreat». Proc. Natl. Acad. Sci. U.S.A. 94 (11): 5939–42. Bibcode:1997PNAS...94.5939H. doi:10.1073/pnas.94.11.5939. PMC 20885. PMID 9159179.
Perreault HA, Semsar K, Godwin J (2003). «Fluoxetine treatment decreases territorial aggression in a coral reef fish». Physiol. Behav. 79 (4–5): 719–24. doi:10.1016/S0031-9384(03)00211-7. PMID 12954414.
Di Poi C, Darmaillacq AS, Dickel L, Boulouard M, Bellanger C (2013). «Effects of perinatal exposure to waterborne fluoxetine on memory processing in the cuttlefish Sepia officinalis». Aquat. Toxicol. 132–133: 84–91. doi:10.1016/j.aquatox.2013.02.004. PMID 23474317.
Nentwig G (2007). «Effects of pharmaceuticals on aquatic invertebrates. Part II: the antidepressant drug fluoxetine». Arch. Environ. Contam. Toxicol. 52 (2): 163–70. doi:10.1007/s00244-005-7190-7. PMID 17160491.

enfa-europe.eu

«www.enfa-europe.eu» (PDF). Արխիվացված է օրիգինալից (PDF) 2014 թ․ մայիսի 23-ին.

europa.eu

ema.europa.eu

Serotonin and noradrenaline reuptake inhibitors (SNRI); selective serotonin reuptake inhibitors (SSRI) – Persistent sexual dysfunction after drug withdrawal (EPITT no 19277), 11 June 20191, EMA/PRAC/265221/2019, Pharmacovigilance Risk Assessment Committee (PRAC)

fda.gov

«Revisions to Product Labeling» (PDF). FDA. Վերցված է 2018 թ․ նոյեմբերի 10-ին.
«FDA Advising of Risk of Birth Defects with Paxil» (Press release). U.S. Food and Drug Administration. Արխիվացված է օրիգինալից 2013 թ․ դեկտեմբերի 3-ին. Վերցված է 2012 թ․ նոյեմբերի 29-ին.
«FDA Medication Guide for Antidepressants». Արխիվացված օրիգինալից 2014 թ․ օգոստոսի 18-ին. Վերցված է 2014 թ․ հունիսի 5-ին.
«Antidepressant Use in Children, Adolescents, and Adults». Արխիվացված օրիգինալից 2016 թ․ դեկտեմբերի 19-ին.

accessdata.fda.gov

«Sertraline prescribing information» (PDF). Արխիվացված (PDF) օրիգինալից 2015 թ․ հունիսի 16-ին. Վերցված է 2015 թ․ հունվարի 30-ին.
«SPRAVATO™ (esketamine) nasal spray FDA label» (PDF). Food and Drug Administration. 2019 թ․ մարտի 5. Վերցված է 2019 թ․ մարտի 6-ին.

gipdatabank.nl

«GIPdatabank». Gipdatabank.nl. Արխիվացված է օրիգինալից 2008 թ․ դեկտեմբերի 6-ին. Վերցված է 2008 թ․ նոյեմբերի 6-ին.

guidelines.gov

«National Guideline Clearinghouse | Practice guideline for the treatment of patients with eating disorders». 2018 թ․ հուլիսի 5. Արխիվացված է օրիգինալից 2013 թ․ մայիսի 25-ին.

handle.net

hdl.handle.net

Fineberg, N. A.; Brown, A; Reghunandanan, S; Pampaloni, I (2012). «Evidence-based pharmacotherapy of obsessive-compulsive disorder». The International Journal of Neuropsychopharmacology. 15 (8): 1173–91. doi:10.1017/S1461145711001829. hdl:2299/216. PMID 22226028.

harvard.edu

ui.adsabs.harvard.edu

Salvi, Virginio; Grua, Ilaria; Cerveri, Giancarlo; Mencacci, Claudio; Barone-Adesi, Francesco (2017 թ․ հուլիսի 31). Meyre, David (ed.). Կաղապար:CC-PMC. «The risk of new-onset diabetes in antidepressant users – A systematic review and meta-analysis». PLOS ONE. Public Library of Science (PLoS). 12 (7): e0182088. Bibcode:2017PLoSO..1282088S. doi:10.1371/journal.pone.0182088. ISSN 1932-6203. PMC 5536271. PMID 28759599. «In our meta-analysis we found an association between exposure to ADs and new-onset diabetes, with a relative risk of 1.27. When we restricted the analysis to the studies to high NOS score the association between ADs and diabetes was even stronger. The results are in line with those from two previous meta-analyses that reported a 1.5-fold increase of diabetes among AD users.»{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Zhou Z, Zhen J, Karpowich NK, Goetz RM, Law CJ, Reith ME, Wang DN (2007). «LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake». Science. 317 (5843): 1390–3. Bibcode:2007Sci...317.1390Z. doi:10.1126/science.1147614. PMC 3711652. PMID 17690258.
Huber R, Smith K, Delago A, Isaksson K, Kravitz EA (1997). «Serotonin and aggressive motivation in crustaceans: altering the decision to retreat». Proc. Natl. Acad. Sci. U.S.A. 94 (11): 5939–42. Bibcode:1997PNAS...94.5939H. doi:10.1073/pnas.94.11.5939. PMC 20885. PMID 9159179.

jpharmacol.com

Sivagnanam, G (2012). «Antidepressants». Journal of Pharmacology and Pharmacotherapeutics. 3 (3): 287–8. Արխիվացված է օրիգինալից 2018 թ․ հուլիսի 1-ին. Վերցված է 2022 թ․ մայիսի 18-ին.

kcl.ac.uk

kclpure.kcl.ac.uk

Taylor MJ, Rudkin L, Bullemor-Day P, Lubin J, Chukwujekwu C, Hawton K (2013 թ․ մայիս). «Strategies for managing sexual dysfunction induced by antidepressant medication». The Cochrane Database of Systematic Reviews. 5 (5): CD003382. doi:10.1002/14651858.CD003382.pub3. PMID 23728643.
Fornaro, M; Anastasia, A; Novello, S; Fusco, A; Pariano, R; De Berardis, D; Solmi, M; Veronese, N; Stubbs, B; Vieta, E; Berk, M; de Bartolomeis, A; Carvalho, AF (2018 թ․ հոկտեմբերի 29). «The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications». Pharmacological Research. 139: 494–502. doi:10.1016/j.phrs.2018.10.025. PMID 30385364.

latimes.com

Los Angeles Times (2013). «FDA approves a new antidepressant: Brintellix». Արխիվացված օրիգինալից 2015 թ․ նոյեմբերի 20-ին.

medscape.com

reference.medscape.com

«mirtazapine (Rx) – Remeron, Remeron SolTab». Medscape. WebMD. Արխիվացված է օրիգինալից 2013 թ․ հոկտեմբերի 29-ին. Վերցված է 2013 թ․ նոյեմբերի 19-ին.

merckmanuals.com

«Depressive Disorders». Merck Manual. Արխիվացված է օրիգինալից 2013 թ․ դեկտեմբերի 5-ին. Վերցված է 2012 թ․ նոյեմբերի 30-ին.

modernmedicine.com

drugtopics.modernmedicine.com

«Top 200 generic drugs by units in 2010» (PDF). Արխիվացված է օրիգինալից (PDF) 2012 թ․ դեկտեմբերի 15-ին.«Top 200 brand drugs by units in 2010» (PDF). Արխիվացված է օրիգինալից (PDF) 2012 թ․ ապրիլի 22-ին.

nice.org.uk

«Depression in adults: The treatment and management of depression in adults». NICE guidelines [CG90]. National Institute for Health and Care Excellence (UK). 2009 թ․ հոկտեմբեր. Արխիվացված օրիգինալից 2015 թ․ սեպտեմբերի 23-ին. Վերցված է 2015 թ․ սեպտեմբերի 23-ին.
«www.nice.org.uk» (PDF). Արխիվացված է օրիգինալից (PDF) 2012 թ․ հոկտեմբերի 21-ին. Վերցված է 2013 թ․ փետրվարի 20-ին.
«www.nice.org.uk» (PDF). Արխիվացված է օրիգինալից (PDF) 2008 թ․ դեկտեմբերի 6-ին.
«www.nice.org.uk» (PDF). Արխիվացված (PDF) օրիգինալից 2014 թ․ մարտի 27-ին.
«www.nice.org.uk» (PDF). Արխիվացված (PDF) օրիգինալից 2012 թ․ հոկտեմբերի 18-ին.

nih.gov

pubmed.ncbi.nlm.nih.gov

Healy D, Noury LJ, Manginb D (2018 թ․ մայիս). «Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases». International Journal of Risk & Safety in Medicine. 29 (3): 125–134. doi:10.3233/JRS-180744. PMC 6004900. PMID 29733030.
Taylor MJ, Rudkin L, Bullemor-Day P, Lubin J, Chukwujekwu C, Hawton K (2013 թ․ մայիս). «Strategies for managing sexual dysfunction induced by antidepressant medication». The Cochrane Database of Systematic Reviews. 5 (5): CD003382. doi:10.1002/14651858.CD003382.pub3. PMID 23728643.
Kennedy SH, Rizvi S (2009 թ․ ապրիլ). «Sexual dysfunction, depression, and the impact of antidepressants». Journal of Clinical Psychopharmacology. 29 (2): 157–64. doi:10.1097/jcp.0b013e31819c76e9. PMID 19512977.
Wilson, E; Lader, M (2015 թ․ դեկտեմբեր). «A review of the management of antidepressant discontinuation symptoms». Therapeutic Advances in Psychopharmacology. 5 (6): 357–68. doi:10.1177/2045125315612334. PMC 4722507. PMID 26834969.
Gabriel, M; Sharma, V (2017 թ․ մայիսի 29). «Antidepressant discontinuation syndrome». Canadian Medical Association Journal. 189 (21): E747. doi:10.1503/cmaj.160991. PMC 5449237. PMID 28554948.
Cipriani, Andrea; Furukawa, Toshi A; Salanti, Georgia; Chaimani, Anna; Atkinson, Lauren Z; Ogawa, Yusuke; Leucht, Stefan; Ruhe, Henricus G; Turner, Erick H; Higgins, Julian P T; Egger, Matthias; Takeshima, Nozomi; Hayasaka, Yu; Imai, Hissei; Shinohara, Kiyomi; Tajika, Aran; Ioannidis, John P A; Geddes, John R (2018). «Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». The Lancet. 391 (10128): 1357–1366. doi:10.1016/S0140-6736(17)32802-7. ISSN 0140-6736. PMC 5889788. PMID 29477251.
Barth, Michael; Kriston, Levente; Klostermann, Swaantje; Barbui, Corrado; Cipriani, Andrea; Linde, Klaus (2018). «Efficacy of selective serotonin reuptake inhibitors and adverse events: Meta-regression and mediation analysis of placebo-controlled trials». British Journal of Psychiatry. 208 (2): 114–119. doi:10.1192/bjp.bp.114.150136. ISSN 0007-1250. PMID 26834168.
Jakobsen, JC; Gluud, C; Kirsch, I (2019 թ․ սեպտեմբերի 25). «Should antidepressants be used for major depressive disorder?». BMJ Evidence-based Medicine: bmjebm–2019–111238. doi:10.1136/bmjebm-2019-111238. PMID 31554608.
Cipriani, Andrea; Zhou, Xinyu; Del Giovane, Cinzia; Hetrick, Sarah E; Qin, Bin; Whittington, Craig; Coghill, David; Zhang, Yuqing; Hazell, Philip; Leucht, Stefan; Cuijpers, Pim; Pu, Juncai; Cohen, David; Ravindran, Arun V; Liu, Yiyun; Michael, Kurt D; Yang, Lining; Liu, Lanxiang; Xie, Peng (2016). «Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis». The Lancet. 388 (10047): 881–890. doi:10.1016/S0140-6736(16)30385-3. ISSN 0140-6736. PMID 27289172. «When considering the risk-benefit profile of antidepressants in the acute treatment of major depressive disorder, these drugs do not seem to offer a clear advantage for children and adolescents.»
Turner, Erick H; Rosenthal, Robert (2008). «Efficacy of antidepressants». BMJ. 336 (7643): 516–517. doi:10.1136/bmj.39510.531597.80. ISSN 0959-8138. PMC 2265347. PMID 18319297.
Kirsch, Irving (2014). «Antidepressants and the Placebo Effect». Zeitschrift für Psychologie. 222 (3): 128–134. doi:10.1027/2151-2604/a000176. ISSN 2190-8370. PMC 4172306. PMID 25279271.
Hansen, Richard A.; Gaynes, Bradley N.; Gartlehner, Gerald; Moore, Charity G.; Tiwari, Ruchi; Lohr, Kathleen N. (2008 թ․ մայիս). «Efficacy and Tolerability of Second-Generation Antidepressants in Social Anxiety Disorder». International Clinical Psychopharmacology. 23 (3): 170–179. doi:10.1097/YIC.0b013e3282f4224a. ISSN 0268-1315. PMC 2657552. PMID 18408531.
Canton, John; Scott, Kate M; Glue, Paul (2012). «Optimal treatment of social phobia: systematic review and meta-analysis». Neuropsychiatric Disease and Treatment. 8: 203–215. doi:10.2147/NDT.S23317. ISSN 1176-6328. PMC 3363138. PMID 22665997.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Soomro, GM; Altman, D; Rajagopal, S; Oakley-Browne, M (2008 թ․ հունվարի 23). «Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)». The Cochrane Database of Systematic Reviews (1): CD001765. doi:10.1002/14651858.CD001765.pub3. PMID 18253995.
Fineberg, N. A.; Brown, A; Reghunandanan, S; Pampaloni, I (2012). «Evidence-based pharmacotherapy of obsessive-compulsive disorder». The International Journal of Neuropsychopharmacology. 15 (8): 1173–91. doi:10.1017/S1461145711001829. hdl:2299/216. PMID 22226028.
Kellner, Michael (2010 թ․ հունիս). «Drug treatment of obsessive-compulsive disorder». Dialogues in Clinical Neuroscience. 12 (2): 187–197. ISSN 1294-8322. PMC 3181958. PMID 20623923.
Alexander, Walter (2012 թ․ հունվար). «Pharmacotherapy for Post-traumatic Stress Disorder In Combat Veterans». Pharmacy and Therapeutics. 37 (1): 32–38. ISSN 1052-1372. PMC 3278188. PMID 22346334.
Bighelli, Irene; Castellazzi, Mariasole; Cipriani, Andrea; Girlanda, Francesca; Guaiana, Giuseppe; Koesters, Markus; Turrini, Giulia; Furukawa, Toshi A.; Barbui, Corrado (2018 թ․ ապրիլի 5). «Antidepressants versus placebo for panic disorder in adults». The Cochrane Database of Systematic Reviews. 4: CD010676. doi:10.1002/14651858.CD010676.pub2. ISSN 1469-493X. PMC 6494573. PMID 29620793.
Andrisano, Costanza; Chiesa, Alberto; Serretti, Alessandro (2013 թ․ հունվար). «Newer antidepressants and panic disorder: a meta-analysis». International Clinical Psychopharmacology. 28 (1): 33–45. doi:10.1097/YIC.0b013e32835a5d2e. ISSN 1473-5857. PMID 23111544.
Bighelli, Irene; Trespidi, Carlotta; Castellazzi, Mariasole; Cipriani, Andrea; Furukawa, Toshi A.; Girlanda, Francesca; Guaiana, Giuseppe; Koesters, Markus; Barbui, Corrado (2016 թ․ սեպտեմբերի 12). «Antidepressants and benzodiazepines for panic disorder in adults». The Cochrane Database of Systematic Reviews. 9: CD011567. doi:10.1002/14651858.CD011567.pub2. ISSN 1469-493X. PMC 6457579. PMID 27618521.
Flament MF, Bissada H, Spettigue W (2012 թ․ մարտ). «Evidence-based pharmacotherapy of eating disorders». Int. J. Neuropsychopharmacol. 15 (2): 189–207. doi:10.1017/S1461145711000381. PMID 21414249.
Häuser W, Wolfe F, Tölle T, Uçeyler N, Sommer C (2012 թ․ ապրիլ). «The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis». CNS Drugs. 26 (4): 297–307. doi:10.2165/11598970-000000000-00000. PMID 22452526.
Lunn MP, Hughes RA, Wiffen PJ (2014). «Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia». Cochrane Database Syst Rev. 1 (1): CD007115. doi:10.1002/14651858.CD007115.pub3. PMID 24385423.
Moore, R. Andrew; Derry, Sheena; Aldington, Dominic; Cole, Peter; Wiffen, Philip J. (2015 թ․ հուլիսի 6). «Amitriptyline for neuropathic pain in adults». The Cochrane Database of Systematic Reviews (7): CD008242. doi:10.1002/14651858.CD008242.pub3. ISSN 1469-493X. PMC 6447238. PMID 26146793.
Agabio, Roberta; Trogu, Emanuela; Pani, Pier Paolo (2018). «Antidepressants for the treatment of people with co-occurring depression and alcohol dependence». The Cochrane Database of Systematic Reviews. 4: CD008581. doi:10.1002/14651858.CD008581.pub2. ISSN 1469-493X. PMC 6494437. PMID 29688573.
Richards, Bethan L; Whittle, Samuel L; Buchbinder, Rachelle (2011 թ․ նոյեմբերի 9). «Antidepressants for pain management in rheumatoid arthritis». Cochrane Database of Systematic Reviews (11): CD008920. doi:10.1002/14651858.cd008920.pub2. ISSN 1465-1858. PMID 22071859.
Baghai TC, Möller HJ, Rupprecht R (2006). «Recent Progress in Pharmacological and Non-Pharmacological Treatment Options of Major Depression». Current Pharmaceutical Design. 12 (4): 503–15. doi:10.2174/138161206775474422. PMID 16472142.
Ruhé HG, Huyser J, Swinkels JA, Schene AH (2006). «Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder». The Journal of Clinical Psychiatry. 67 (12): 1836–55. doi:10.4088/JCP.v67n1203. PMID 17194261.
Tranter R, O'Donovan C, Chandarana P, Kennedy S (2002). «Prevalence and outcome of partial remission in depression». Journal of Psychiatry & Neuroscience. 27 (4): 241–7. PMC 161658. PMID 12174733.
Byrne SE, Rothschild AJ (1998). «Loss of Antidepressant Efficacy During Maintenance Therapy». The Journal of Clinical Psychiatry. 59 (6): 279–88. doi:10.4088/JCP.v59n0602. PMID 9671339.
Mischoulon D, Nierenberg AA, Kizilbash L, Rosenbaum JF, Fava M (2000). «Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: A survey of clinicians». Canadian Journal of Psychiatry. 45 (5): 476–81. doi:10.1177/070674370004500509. PMID 10900529.
DeBattista C, Lembke A (2005). «Update on augmentation of antidepressant response in resistant depression». Current Psychiatry Reports. 7 (6): 435–40. doi:10.1007/s11920-005-0064-x. PMID 16318821.
Lam RW, Wan DD, Cohen NL, Kennedy SH (2002). «Combining Antidepressants for Treatment-Resistant Depression». The Journal of Clinical Psychiatry. 63 (8): 685–93. doi:10.4088/JCP.v63n0805. PMID 12197448.
Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH (2013). «Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials». The Journal of Clinical Psychiatry. 74 (11): 1101–7. doi:10.4088/JCP.13r08560. PMID 24330897.
Birmes P, Coppin D, Schmitt L, Lauque D (2003). «Serotonin syndrome: a brief review». CMAJ. 168 (11): 1439–42. PMC 155963. PMID 12771076.
Boyer EW, Shannon M (2005). «The serotonin syndrome» (PDF). N. Engl. J. Med. 352 (11): 1112–20. doi:10.1056/NEJMra041867. PMID 15784664. Արխիվացված է օրիգինալից (PDF) 2013 թ․ հունիսի 18-ին.
Mason PJ, Morris VA, Balcezak TJ (2000). «Serotonin syndrome. Presentation of 2 cases and review of the literature». Medicine. 79 (4): 201–9. doi:10.1097/00005792-200007000-00001. PMID 10941349.
Sampson E, Warner JP (1999). «Serotonin syndrome: potentially fatal but difficult to recognize». Br J Gen Pract. 49 (448): 867–8. PMC 1313553. PMID 10818648.
Salvi, Virginio; Grua, Ilaria; Cerveri, Giancarlo; Mencacci, Claudio; Barone-Adesi, Francesco (2017 թ․ հուլիսի 31). Meyre, David (ed.). Կաղապար:CC-PMC. «The risk of new-onset diabetes in antidepressant users – A systematic review and meta-analysis». PLOS ONE. Public Library of Science (PLoS). 12 (7): e0182088. Bibcode:2017PLoSO..1282088S. doi:10.1371/journal.pone.0182088. ISSN 1932-6203. PMC 5536271. PMID 28759599. «In our meta-analysis we found an association between exposure to ADs and new-onset diabetes, with a relative risk of 1.27. When we restricted the analysis to the studies to high NOS score the association between ADs and diabetes was even stronger. The results are in line with those from two previous meta-analyses that reported a 1.5-fold increase of diabetes among AD users.»{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Sathyanarayana Rao TS, Yeragani VK (2009). «Hypertensive crisis and cheese». Indian J Psychiatry. 51 (1): 65–6. doi:10.4103/0019-5545.44910. PMC 2738414. PMID 19742203.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Paykel ES (1995). «Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression». Acta Psychiatr Scand Suppl. 386: 22–7. doi:10.1111/j.1600-0447.1995.tb05920.x. PMID 7717091.
Malm H (2012 թ․ դեկտեմբեր). «Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome». Ther Drug Monit. 34 (6): 607–14. doi:10.1097/FTD.0b013e31826d07ea. PMID 23042258.
Rahimi R, Nikfar S, Abdollahi M (2006). «Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials». Reproductive Toxicology. 22 (4): 571–575. doi:10.1016/j.reprotox.2006.03.019. PMID 16720091.
Nikfar S, Rahimi R, Hendoiee N, Abdollahi M (2012). «Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis». Daru. 20 (1): 75. doi:10.1186/2008-2231-20-75. PMC 3556001. PMID 23351929.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Huang H, Coleman S, Bridge JA, Yonkers K, Katon W (2014). «A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight». General Hospital Psychiatry. 36 (1): 13–8. doi:10.1016/j.genhosppsych.2013.08.002. PMC 3877723. PMID 24094568.
Einarson TR, Kennedy D, Einarson A (2012). «Do findings differ across research design? The case of antidepressant use in pregnancy and malformations». J Popul Ther Clin Pharmacol. 19 (2): e334–48. PMID 22946124.
Riggin L, Frankel Z, Moretti M, Pupco A, Koren G (2013 թ․ ապրիլ). «The fetal safety of fluoxetine: a systematic review and meta-analysis». J Obstet Gynaecol Can. 35 (4): 362–9. doi:10.1016/S1701-2163(15)30965-8. PMID 23660045.
Koren G, Nordeng HM (2013 թ․ փետրվար). «Selective serotonin reuptake inhibitors and malformations: case closed?». Semin Fetal Neonatal Med. 18 (1): 19–22. doi:10.1016/j.siny.2012.10.004. PMID 23228547.
Ross, Lori E.; Grigoriadis, Sophie; Mamisashvili, Lana; VonderPorten, Emily H.; Roerecke, Michael; Rehm, Jürgen; Dennis, Cindy-Lee; Koren, Gideon; Steiner, Meir; Mousmanis, Patricia; Cheung, Amy (2013 թ․ ապրիլի 1). «Selected Pregnancy and Delivery Outcomes After Exposure to Antidepressant Medication». JAMA Psychiatry. 70 (4): 436–43. doi:10.1001/jamapsychiatry.2013.684. PMID 23446732.
Lanza di Scalea T, Wisner KL (2009). «Antidepressant Medication Use During Breastfeeding». Clinical Obstetrics and Gynecology. 52 (3): 483–97. doi:10.1097/GRF.0b013e3181b52bd6. PMC 2902256. PMID 19661763.
Goldberg JF, Truman CJ (2003). «Antidepressant-induced mania: An overview of current controversies». Bipolar Disorders. 5 (6): 407–20. doi:10.1046/j.1399-5618.2003.00067.x. PMID 14636364.
Benazzi F (1997). «Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice». J Affect Disord. 46 (1): 73–7. doi:10.1016/S0165-0327(97)00082-7. PMID 9387089.
Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G (2009). «Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration». BMJ. 339: b2880. doi:10.1136/bmj.b2880. PMC 2725270. PMID 19671933.
Friedman RA, Leon AC (2007). «Expanding the black box – depression, antidepressants, and the risk of suicide». N. Engl. J. Med. 356 (23): 2343–6. doi:10.1056/NEJMp078015. PMID 17485726.
Healy D, Aldred G (2005). «Antidepressant drug use and the risk of suicide» (PDF). International Review of Psychiatry. 17 (3): 163–172. doi:10.1080/09540260500071624. PMID 16194787. Արխիվացված է օրիգինալից (PDF) 2013 թ․ հոկտեմբերի 21-ին.
Healy, David; Le Noury, Joanna; Mangin, Derelie (2018 թ․ հունիսի 4). «Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases». International Journal of Risk & Safety in Medicine. 29 (3–4): 125–134. doi:10.3233/JRS-180744. PMC 6004900. PMID 29733030.
Csoka AB, Csoka A, Bahrick A, Mehtonen OP (2008). «Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors». J Sex Med. 5 (1): 227–33. doi:10.1111/j.1743-6109.2007.00630.x. PMID 18173768.
Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F (2001). «Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction». J Clin Psychiatry. 62 Suppl 3: 10–21. PMID 11229449.
Serretti A, Chiesa A (2009). «Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis». J Clin Psychopharmacol. 29 (3): 259–66. doi:10.1097/JCP.0b013e3181a5233f. PMID 19440080.
Chebili S, Abaoub A, Mezouane B, Le Goff JF (1998). «[Antidepressants and sexual stimulation: the correlation]». Encephale (French). 24 (3): 180–4. PMID 9696909.{{cite journal}}: CS1 սպաս․ չճանաչված լեզու (link)
Keltner NL, McAfee KM, Taylor CL (2009). «Biological Perspectives». Perspectives in Psychiatric Care. 38 (3): 111–6. doi:10.1111/j.1744-6163.2002.tb00665.x. PMID 12385082.
Ozmenler NK, Karlidere T, Bozkurt A, Yetkin S, Doruk A, Sutcigil L, Cansever A, Uzun O, Ozgen F, Ozsahin A (2008). «Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors». Hum Psychopharmacol. 23 (4): 321–6. doi:10.1002/hup.929. PMID 18278806.
Schwasinger-Schmidt, TE; Macaluso, M (2018 թ․ սեպտեմբերի 8). «Other Antidepressants». Handbook of Experimental Pharmacology. 250: 325–355. doi:10.1007/164_2018_167. ISBN 978-3-030-10948-6. PMID 30194544.
Stimmel GL, Dopheide JA, Stahl SM (1997). «Mirtazapine: An antidepressant with noradrenergic and specific serotonergic effects». Pharmacotherapy. 17 (1): 10–21. doi:10.1002/j.1875-9114.1997.tb03674.x (inactive 2020 թ․ հունվարի 16). PMID 9017762. Արխիվացված է օրիգինալից 2021 թ․ մայիսի 25-ին. Վերցված է 2020 թ․ հունվարի 28-ին.{{cite journal}}: CS1 սպաս․ DOI inactive as of 2020 (link)
Papakostas GI (2008). «Tolerability of modern antidepressants». J Clin Psychiatry. 69 (Suppl E1): 8–13. PMID 18494538.
Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR, Hilton L, Suttorp M, Solomon V, Shekelle PG, Morton SC (2005 թ․ ապրիլ). «Meta-analysis: pharmacologic treatment of obesity». Ann. Intern. Med. 142 (7): 532–46. doi:10.7326/0003-4819-142-7-200504050-00012. PMID 15809465.
Warner, CH; Bobo, W; Warner, C; Reid, S; Rachal, J (2006 թ․ օգոստոսի 1). «Antidepressant discontinuation syndrome». American Family Physician. 74 (3): 449–56. PMID 16913164.
Davies, J; Read, J (2018 թ․ սեպտեմբերի 4). «A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?». Addictive Behaviors. 97: 111–121. doi:10.1016/j.addbeh.2018.08.027. PMID 30292574.
Pringle, A; McCabe, C; Cowen, PJ; Harmer, CJ (2013 թ․ օգոստոս). «Antidepressant treatment and emotional processing: can we dissociate the roles of serotonin and noradrenaline?». Journal of Psychopharmacology (Oxford, England). 27 (8): 719–31. doi:10.1177/0269881112474523. PMID 23392757.
Fornaro, M; Anastasia, A; Novello, S; Fusco, A; Pariano, R; De Berardis, D; Solmi, M; Veronese, N; Stubbs, B; Vieta, E; Berk, M; de Bartolomeis, A; Carvalho, AF (2018 թ․ հոկտեմբերի 29). «The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications». Pharmacological Research. 139: 494–502. doi:10.1016/j.phrs.2018.10.025. PMID 30385364.
Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, Kubera M, Bob P, Lerer B, Maj M (2009 թ․ մարտ). «The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression». Metabolic Brain Disease. 24 (1): 27–53. doi:10.1007/s11011-008-9118-1. PMID 19085093.
Sanacora G, Treccani G, Popoli M (2012 թ․ հունվար). «Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders». Neuropharmacology. 62 (1): 63–77. doi:10.1016/j.neuropharm.2011.07.036. PMC 3205453. PMID 21827775.
Menke A, Klengel T, Binder EB (2012). «Epigenetics, depression and antidepressant treatment». Current Pharmaceutical Design. 18 (36): 5879–5889. doi:10.2174/138161212803523590. PMID 22681167.
Vialou V, Feng J, Robison AJ, Nestler EJ (2013 թ․ հունվար). «Epigenetic mechanisms of depression and antidepressant action». Annual Review of Pharmacology and Toxicology. 53 (1): 59–87. doi:10.1146/annurev-pharmtox-010611-134540. PMC 3711377. PMID 23020296.
Pies R (2010 թ․ ապրիլ). «Antidepressants Work, Sort of-Our System of Care Does Not». Journal of Clinical Psychopharmacology. 30 (2): 101–104. doi:10.1097/JCP.0b013e3181d52dea. PMID 20520282.
Fournier, JC; DeRubeis, RJ; Hollon, SD; Dimidjian, S; Amsterdam, JD; Shelton, RC; Fawcett, J (2010 թ․ հունվարի 6). «Antidepressant drug effects and depression severity: a patient-level meta-analysis». JAMA. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569.
Pies, Ronald W. (2016). «Antidepressants». Journal of Clinical Psychopharmacology. 36 (1): 1–4. doi:10.1097/jcp.0000000000000455. PMID 26658086.
Cashman, JR; Ghirmai, S (2009). «Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression». Bioorganic & Medicinal Chemistry. 17 (19): 6890–7. doi:10.1016/j.bmc.2009.08.025. PMID 19740668.
Goldenberg MM (2013 թ․ նոյեմբեր). «Pharmaceutical approval update». P T. 38 (11): 705–7. PMC 3875258. PMID 24391391.
Hughes ZA, Starr KR, Langmead CJ, և այլք: (2005 թ․ մարտ). «Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone». European Journal of Pharmacology. 510 (1–2): 49–57. doi:10.1016/j.ejphar.2005.01.018. PMID 15740724.
Gasior M, Bergman J, Kallman MJ, Paronis CA (2005 թ․ ապրիլ). «Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys». Neuropsychopharmacology. 30 (4): 758–64. doi:10.1038/sj.npp.1300593. PMID 15526000.
Wee S, Woolverton WL (2004 թ․ սեպտեմբեր). «Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine». Drug and Alcohol Dependence. 75 (3): 271–6. doi:10.1016/j.drugalcdep.2004.03.010. PMID 15283948.
Rothman RB, Baumann MH, Dersch CM, և այլք: (2001 թ․ հունվար). «Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin». Synapse. 39 (1): 32–41. doi:10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3. PMID 11071707.
Tatsumi M, Groshan K, Blakely RD, Richelson E (1997). «Pharmacological profile of antidepressants and related compounds at human monoamine transporters». Eur J Pharmacol. 340 (2–3): 249–258. doi:10.1016/S0014-2999(97)01393-9. PMID 9537821.
Gillman PK (2007 թ․ հուլիս). «Tricyclic antidepressant pharmacology and therapeutic drug interactions updated». British Journal of Pharmacology. 151 (6): 737–48. doi:10.1038/sj.bjp.0707253. PMC 2014120. PMID 17471183.
Trindade, E.; Menon, D.; Topfer, L. A.; Coloma, C. (1998 թ․ նոյեմբերի 17). «Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis». Canadian Medical Association Journal. 159 (10): 1245–1252. PMC 1229819. PMID 9861221.
Buigues, J; Vallejo, J (1987). «Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks». Journal of Clinical Psychiatry. 48 (2): 55–9. PMID 3542985.
Liebowitz, MR; Schneier, FR; Campeas, R; Hollander, E; Hatterer, J; Fyer, A; և այլք: (1992). «Phenelzine vs atenolol in social phobia: A placebo-controlled comparison». Archives of General Psychiatry. 49 (4): 290–300. doi:10.1001/archpsyc.49.4.290. PMID 1558463.
Versiani M, Nardi AE, Mundim FD, Alves AB, Liebowitz MR, Amrein R. Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine. BJP [Internet]. 1992 Sep 1 [cited 2013 Oct 4];161(3):353–60. Available from: Versiani, M.; Nardi, A. E.; Mundim, F. D.; Alves, A. B.; Liebowitz, M. R.; Amrein, R. (1992). «Pharmacotherapy of Social Phobia». British Journal of Psychiatry. 161 (3): 353–360. doi:10.1192/bjp.161.3.353. PMID 1393304.
Heimberg, RG; Liebowitz, MR; Hope, DA; և այլք: (1998). «Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome». Arch Gen Psychiatry. 55 (12): 1133–41. doi:10.1001/archpsyc.55.12.1133. PMID 9862558.
Jarrett, RB; Schaffer, M; McIntire, D; Witt-Browder, A; Kraft, D; Risser, RC (1999). «Treatment of atypical depression with cognitive therapy or phenelzine: A double-blind, placebo-controlled trial». Arch Gen Psychiatry. 56 (5): 431–7. doi:10.1001/archpsyc.56.5.431. PMC 1475805. PMID 10232298.
Liebowitz, MR; Quitkin, FM; Stewart, JW; և այլք: (1984). «Phenelzine v imipramine in atypical depression: A preliminary report». Arch Gen Psychiatry. 41 (7): 669–77. doi:10.1001/archpsyc.1984.01790180039005. PMID 6375621.
Walsh, B; Stewart, JW; Roose, SP; Gladis, M; Glassman, AH (1984). «Treatment of bulimia with phenelzine: A double-blind, placebo-controlled study». Arch Gen Psychiatry. 41 (11): 1105–9. doi:10.1001/archpsyc.1983.01790220095015. PMID 6388524.
Rothschild R, Quitkin HM, Quitkin FM, Stewart JW, Ocepek-Welikson K, McGrath PJ, և այլք: (1994). «A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives». International Journal of Eating Disorders. 15 (1): 1–9. doi:10.1002/1098-108X(199401)15:1<1::AID-EAT2260150102>3.0.CO;2-E. PMID 8124322.
Walsh, BT; Stewart, JW; Roose, SP; Gladis, M; Glassman, AH (1985). «A double-blind trial of phenelzine in bulimia». Journal of Psychiatric Research. 19 (2–3): 485–9. doi:10.1016/0022-3956(85)90058-5. PMID 3900362.
Walsh, B; Gladis, M; Roose, SP; Stewart, JW; Stetner, F; Glassman, AH (1988 թ․ մայիս). «Phenelzine vs placebo in 50 patients with bulimia». Arch Gen Psychiatry. 45 (5): 471–5. doi:10.1001/archpsyc.1988.01800290091011. PMID 3282482.
Davidson, J; Ingram, J; Kilts, C (1987). «A pilot study of phenelzine in the treatment of post-traumatic stress disorder». The British Journal of Psychiatry. 150 (2): 252–5. doi:10.1192/bjp.150.2.252. PMID 3651684.
Soloff, PH; Cornelius, J; George, A; Nathan, S; Perel, JM; Ulrich, RF (1993). «Efficacy of phenelzine and haloperidol in borderline personality disorder». Arch Gen Psychiatry. 50 (5): 377–85. doi:10.1001/archpsyc.1993.01820170055007. PMID 8489326.
Mallinger, AG; Frank, E; Thase, ME; Barwell, MM; DiazGranados, N; Luckenbaugh, DA; և այլք: (2009). «Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?». Psychopharmacol Bull. 42 (2): 64–74. PMC 3570273. PMID 19629023.
Liebowitz, MR; Hollander, E; Schneier, F; Campeas, R; Welkowitz, L; Hatterer, J; Fallon, B (1990). «Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders». Acta Psychiatr Scand Suppl. 360: 29–34. doi:10.1111/j.1600-0447.1990.tb05321.x. PMID 2248064.
Cox, Georgina R.; Callahan, Patch; Churchill, Rachel; Hunot, Vivien; Merry, Sally N.; Parker, Alexandra G.; Hetrick, Sarah E. (2014 թ․ նոյեմբերի 30). «Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents» (PDF). The Cochrane Database of Systematic Reviews. 11 (11): CD008324. doi:10.1002/14651858.CD008324.pub3. ISSN 1469-493X. PMID 25433518.
Bauer M, Dopfmer S (1999). «Lithium augmentation in treatment-resistant depression: Meta-analysis of placebo-controlled studies». Journal of Clinical Psychopharmacology. 19 (5): 427–34. doi:10.1097/00004714-199910000-00006. PMID 10505584.
Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ (2007 թ․ մարտ). «Lithium treatment reduces suicide risk in recurrent major depressive disorder». J Clin Psychiatry. 68 (3): 380–83. doi:10.4088/JCP.v68n0304. PMID 17388706.
Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G, Lebowitz B, Shores-Wilson K, Rush AJ (2006). «A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: A STAR*D report». American Journal of Psychiatry. 163 (9): 1519–30. doi:10.1176/appi.ajp.163.9.1519. PMID 16946176.
Kraus MF, Burch EA (1992). «Methylphenidate hydrochloride as an antidepressant: controversy, case studies, and review». South. Med. J. 85 (10): 985–91. doi:10.1097/00007611-199210000-00012. PMID 1411740.
Orr, K; Taylor, D (2007). «Psychostimulants in the treatment of depression : a review of the evidence». CNS Drugs. 21 (3): 239–57. doi:10.2165/00023210-200721030-00004. PMID 17338594.
Heal DJ, Smith SL, Gosden J, Nutt DJ (2013 թ․ հունիս). «Amphetamine, past and present – a pharmacological and clinical perspective». J. Psychopharmacol. 27 (6): 479–96. doi:10.1177/0269881113482532. PMC 3666194. PMID 23539642.
Weber MM, Emrich HM (1988). «Current and Historical Concepts of Opiate Treatment in Psychiatric Disorders». International Clinical Psychopharmacology. 3 (3): 255–66. doi:10.1097/00004850-198807000-00007. PMID 3153713.
Czygan FC (2003). «Kulturgeschichte und Mystik des Johanniskrauts: Vom 2500 Jahre alten Apotropaikum zum aktuellen Antidepressivum» [From a 2500-year-old apotropic comes a current antidepressive. The cultural history and mistique of St. John's wort]. Pharmazie in Unserer Zeit (German). 32 (3): 184–90. doi:10.1002/pauz.200390062. PMID 12784538.{{cite journal}}: CS1 սպաս․ չճանաչված լեզու (link)
Selikoff IJ, Robitzek EH (1952). «Tuberculosis Chemotherapy with Hydrazine Derivatives of Isonicotinic Acid». Chest. 21 (4): 385–438. doi:10.1378/chest.21.4.385. PMID 14906149.
Robitzek EH, Selikoff IJ, Mamlok E, Tendlau A (1953). «Isoniazid and Its Isopropyl Derivative in the Therapy of Tuberculosis in Humans: Comparative Therapeutic and Toxicologic Properties». Chest. 23 (1): 1–15. doi:10.1378/chest.23.1.1. PMID 12998444.
López-Muñoz F, Alamo C, Juckel G, Assion HJ (2007). «Half a Century of Antidepressant Drugs». Journal of Clinical Psychopharmacology. 27 (6): 555–9. doi:10.1097/jcp.0b013e3181bb617. PMID 18004120.
Kuhn R (1958). «The treatment of depressive states with G 22355 (imipramine hydrochloride)». The American Journal of Psychiatry. 115 (5): 459–64. doi:10.1176/ajp.115.5.459. PMID 13583250.
Healy D (1999). «The Three Faces of the Antidepressants: A Critical Commentary on the Clinical-Economic Context of Diagnosis». The Journal of Nervous & Mental Disease. 187 (3): 174–80. doi:10.1097/00005053-199903000-00007. PMID 10086474.
Pletscher A (1991). «The discovery of antidepressants: A winding path». Experientia. 47 (1): 4–8. doi:10.1007/BF02041242. PMID 1999242.
Wong DT, Bymaster FP, Horng JS, Molloy BB (1975). «A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine». The Journal of Pharmacology and Experimental Therapeutics. 193 (3): 804–11. PMID 1151730. Արխիվացված է օրիգինալից 2021 թ․ նոյեմբերի 19-ին. Վերցված է 2020 թ․ հունվարի 30-ին.
Domino EF (1999). «History of modern psychopharmacology: A personal view with an emphasis on antidepressants». Psychosomatic Medicine. 61 (5): 591–8. doi:10.1097/00006842-199909000-00002. PMID 10511010.
Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D (1996). «St John's wort for depression—an overview and meta-analysis of randomised clinical trials». BMJ. 313 (7052): 253–8. doi:10.1136/bmj.313.7052.253. PMC 2351679. PMID 8704532.
Müller WE (2003). «Current St. John's wort research from mode of action to clinical efficacy». Pharmacological Research. 47 (2): 101–9. doi:10.1016/S1043-6618(02)00266-9. PMID 12543057.
Nathan PJ (2001). «Hypericum perforatum (St John's Wort): A non-selective reuptake inhibitor? A review of the recent advances in its pharmacology». Journal of Psychopharmacology. 15 (1): 47–54. doi:10.1177/026988110101500109. PMID 11277608.
Kaplan, Jessica E.; Keeley, Robert D.; Engel, Matthew; Emsermann, Caroline; Brody, David (2013 թ․ հուլիս). «Aspects of patient and clinician language predict adherence to antidepressant medication». Journal of the American Board of Family Medicine: JABFM. 26 (4): 409–420. doi:10.3122/jabfm.2013.04.120201. PMID 23833156.
Ho, SC; Chong, HY; Chaiyakunapruk, N; Tangiisuran, B; Jacob, SA (2016 թ․ մարտի 15). «Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: A systematic review». Journal of Affective Disorders. 193: 1–10. doi:10.1016/j.jad.2015.12.029. PMID 26748881.
Ecks S (2005). «Pharmaceutical Citizenship: Antidepressant Marketing and the Promise of Demarginalization in India». Anthropology & Medicine. 12 (3): 239–254. doi:10.1080/13648470500291360. PMID 26873669.
Zhou Z, Zhen J, Karpowich NK, Goetz RM, Law CJ, Reith ME, Wang DN (2007). «LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake». Science. 317 (5843): 1390–3. Bibcode:2007Sci...317.1390Z. doi:10.1126/science.1147614. PMC 3711652. PMID 17690258.
Brooks BW, Chambliss CK, Stanley JK, Ramirez A, Banks KE, Johnson RD, Lewis RJ (2005). «Determination of select antidepressants in fish from an effluent-dominated stream». Environ. Toxicol. Chem. 24 (2): 464–9. doi:10.1897/04-081r.1. PMID 15720009.
Fent K, Weston AA, Caminada D (2006). «Ecotoxicology of human pharmaceuticals». Aquat. Toxicol. 76 (2): 122–59. doi:10.1016/j.aquatox.2005.09.009. PMID 16257063.
Huber R, Smith K, Delago A, Isaksson K, Kravitz EA (1997). «Serotonin and aggressive motivation in crustaceans: altering the decision to retreat». Proc. Natl. Acad. Sci. U.S.A. 94 (11): 5939–42. Bibcode:1997PNAS...94.5939H. doi:10.1073/pnas.94.11.5939. PMC 20885. PMID 9159179.
Perreault HA, Semsar K, Godwin J (2003). «Fluoxetine treatment decreases territorial aggression in a coral reef fish». Physiol. Behav. 79 (4–5): 719–24. doi:10.1016/S0031-9384(03)00211-7. PMID 12954414.
Di Poi C, Darmaillacq AS, Dickel L, Boulouard M, Bellanger C (2013). «Effects of perinatal exposure to waterborne fluoxetine on memory processing in the cuttlefish Sepia officinalis». Aquat. Toxicol. 132–133: 84–91. doi:10.1016/j.aquatox.2013.02.004. PMID 23474317.
Nentwig G (2007). «Effects of pharmaceuticals on aquatic invertebrates. Part II: the antidepressant drug fluoxetine». Arch. Environ. Contam. Toxicol. 52 (2): 163–70. doi:10.1007/s00244-005-7190-7. PMID 17160491.

ncbi.nlm.nih.gov

Healy D, Noury LJ, Manginb D (2018 թ․ մայիս). «Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases». International Journal of Risk & Safety in Medicine. 29 (3): 125–134. doi:10.3233/JRS-180744. PMC 6004900. PMID 29733030.
Wilson, E; Lader, M (2015 թ․ դեկտեմբեր). «A review of the management of antidepressant discontinuation symptoms». Therapeutic Advances in Psychopharmacology. 5 (6): 357–68. doi:10.1177/2045125315612334. PMC 4722507. PMID 26834969.
Gabriel, M; Sharma, V (2017 թ․ մայիսի 29). «Antidepressant discontinuation syndrome». Canadian Medical Association Journal. 189 (21): E747. doi:10.1503/cmaj.160991. PMC 5449237. PMID 28554948.
Cipriani, Andrea; Furukawa, Toshi A; Salanti, Georgia; Chaimani, Anna; Atkinson, Lauren Z; Ogawa, Yusuke; Leucht, Stefan; Ruhe, Henricus G; Turner, Erick H; Higgins, Julian P T; Egger, Matthias; Takeshima, Nozomi; Hayasaka, Yu; Imai, Hissei; Shinohara, Kiyomi; Tajika, Aran; Ioannidis, John P A; Geddes, John R (2018). «Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». The Lancet. 391 (10128): 1357–1366. doi:10.1016/S0140-6736(17)32802-7. ISSN 0140-6736. PMC 5889788. PMID 29477251.
Turner, Erick H; Rosenthal, Robert (2008). «Efficacy of antidepressants». BMJ. 336 (7643): 516–517. doi:10.1136/bmj.39510.531597.80. ISSN 0959-8138. PMC 2265347. PMID 18319297.
Kirsch, Irving (2014). «Antidepressants and the Placebo Effect». Zeitschrift für Psychologie. 222 (3): 128–134. doi:10.1027/2151-2604/a000176. ISSN 2190-8370. PMC 4172306. PMID 25279271.
Hansen, Richard A.; Gaynes, Bradley N.; Gartlehner, Gerald; Moore, Charity G.; Tiwari, Ruchi; Lohr, Kathleen N. (2008 թ․ մայիս). «Efficacy and Tolerability of Second-Generation Antidepressants in Social Anxiety Disorder». International Clinical Psychopharmacology. 23 (3): 170–179. doi:10.1097/YIC.0b013e3282f4224a. ISSN 0268-1315. PMC 2657552. PMID 18408531.
Canton, John; Scott, Kate M; Glue, Paul (2012). «Optimal treatment of social phobia: systematic review and meta-analysis». Neuropsychiatric Disease and Treatment. 8: 203–215. doi:10.2147/NDT.S23317. ISSN 1176-6328. PMC 3363138. PMID 22665997.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Kellner, Michael (2010 թ․ հունիս). «Drug treatment of obsessive-compulsive disorder». Dialogues in Clinical Neuroscience. 12 (2): 187–197. ISSN 1294-8322. PMC 3181958. PMID 20623923.
Alexander, Walter (2012 թ․ հունվար). «Pharmacotherapy for Post-traumatic Stress Disorder In Combat Veterans». Pharmacy and Therapeutics. 37 (1): 32–38. ISSN 1052-1372. PMC 3278188. PMID 22346334.
Bighelli, Irene; Castellazzi, Mariasole; Cipriani, Andrea; Girlanda, Francesca; Guaiana, Giuseppe; Koesters, Markus; Turrini, Giulia; Furukawa, Toshi A.; Barbui, Corrado (2018 թ․ ապրիլի 5). «Antidepressants versus placebo for panic disorder in adults». The Cochrane Database of Systematic Reviews. 4: CD010676. doi:10.1002/14651858.CD010676.pub2. ISSN 1469-493X. PMC 6494573. PMID 29620793.
Bighelli, Irene; Trespidi, Carlotta; Castellazzi, Mariasole; Cipriani, Andrea; Furukawa, Toshi A.; Girlanda, Francesca; Guaiana, Giuseppe; Koesters, Markus; Barbui, Corrado (2016 թ․ սեպտեմբերի 12). «Antidepressants and benzodiazepines for panic disorder in adults». The Cochrane Database of Systematic Reviews. 9: CD011567. doi:10.1002/14651858.CD011567.pub2. ISSN 1469-493X. PMC 6457579. PMID 27618521.
Moore, R. Andrew; Derry, Sheena; Aldington, Dominic; Cole, Peter; Wiffen, Philip J. (2015 թ․ հուլիսի 6). «Amitriptyline for neuropathic pain in adults». The Cochrane Database of Systematic Reviews (7): CD008242. doi:10.1002/14651858.CD008242.pub3. ISSN 1469-493X. PMC 6447238. PMID 26146793.
Agabio, Roberta; Trogu, Emanuela; Pani, Pier Paolo (2018). «Antidepressants for the treatment of people with co-occurring depression and alcohol dependence». The Cochrane Database of Systematic Reviews. 4: CD008581. doi:10.1002/14651858.CD008581.pub2. ISSN 1469-493X. PMC 6494437. PMID 29688573.
Tranter R, O'Donovan C, Chandarana P, Kennedy S (2002). «Prevalence and outcome of partial remission in depression». Journal of Psychiatry & Neuroscience. 27 (4): 241–7. PMC 161658. PMID 12174733.
Birmes P, Coppin D, Schmitt L, Lauque D (2003). «Serotonin syndrome: a brief review». CMAJ. 168 (11): 1439–42. PMC 155963. PMID 12771076.
Sampson E, Warner JP (1999). «Serotonin syndrome: potentially fatal but difficult to recognize». Br J Gen Pract. 49 (448): 867–8. PMC 1313553. PMID 10818648.
Salvi, Virginio; Grua, Ilaria; Cerveri, Giancarlo; Mencacci, Claudio; Barone-Adesi, Francesco (2017 թ․ հուլիսի 31). Meyre, David (ed.). Կաղապար:CC-PMC. «The risk of new-onset diabetes in antidepressant users – A systematic review and meta-analysis». PLOS ONE. Public Library of Science (PLoS). 12 (7): e0182088. Bibcode:2017PLoSO..1282088S. doi:10.1371/journal.pone.0182088. ISSN 1932-6203. PMC 5536271. PMID 28759599. «In our meta-analysis we found an association between exposure to ADs and new-onset diabetes, with a relative risk of 1.27. When we restricted the analysis to the studies to high NOS score the association between ADs and diabetes was even stronger. The results are in line with those from two previous meta-analyses that reported a 1.5-fold increase of diabetes among AD users.»{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Sathyanarayana Rao TS, Yeragani VK (2009). «Hypertensive crisis and cheese». Indian J Psychiatry. 51 (1): 65–6. doi:10.4103/0019-5545.44910. PMC 2738414. PMID 19742203.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Nikfar S, Rahimi R, Hendoiee N, Abdollahi M (2012). «Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis». Daru. 20 (1): 75. doi:10.1186/2008-2231-20-75. PMC 3556001. PMID 23351929.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Huang H, Coleman S, Bridge JA, Yonkers K, Katon W (2014). «A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight». General Hospital Psychiatry. 36 (1): 13–8. doi:10.1016/j.genhosppsych.2013.08.002. PMC 3877723. PMID 24094568.
Lanza di Scalea T, Wisner KL (2009). «Antidepressant Medication Use During Breastfeeding». Clinical Obstetrics and Gynecology. 52 (3): 483–97. doi:10.1097/GRF.0b013e3181b52bd6. PMC 2902256. PMID 19661763.
Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G (2009). «Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration». BMJ. 339: b2880. doi:10.1136/bmj.b2880. PMC 2725270. PMID 19671933.
Healy, David; Le Noury, Joanna; Mangin, Derelie (2018 թ․ հունիսի 4). «Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases». International Journal of Risk & Safety in Medicine. 29 (3–4): 125–134. doi:10.3233/JRS-180744. PMC 6004900. PMID 29733030.
Sanacora G, Treccani G, Popoli M (2012 թ․ հունվար). «Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders». Neuropharmacology. 62 (1): 63–77. doi:10.1016/j.neuropharm.2011.07.036. PMC 3205453. PMID 21827775.
Vialou V, Feng J, Robison AJ, Nestler EJ (2013 թ․ հունվար). «Epigenetic mechanisms of depression and antidepressant action». Annual Review of Pharmacology and Toxicology. 53 (1): 59–87. doi:10.1146/annurev-pharmtox-010611-134540. PMC 3711377. PMID 23020296.
Fournier, JC; DeRubeis, RJ; Hollon, SD; Dimidjian, S; Amsterdam, JD; Shelton, RC; Fawcett, J (2010 թ․ հունվարի 6). «Antidepressant drug effects and depression severity: a patient-level meta-analysis». JAMA. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569.
Goldenberg MM (2013 թ․ նոյեմբեր). «Pharmaceutical approval update». P T. 38 (11): 705–7. PMC 3875258. PMID 24391391.
Gillman PK (2007 թ․ հուլիս). «Tricyclic antidepressant pharmacology and therapeutic drug interactions updated». British Journal of Pharmacology. 151 (6): 737–48. doi:10.1038/sj.bjp.0707253. PMC 2014120. PMID 17471183.
Trindade, E.; Menon, D.; Topfer, L. A.; Coloma, C. (1998 թ․ նոյեմբերի 17). «Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis». Canadian Medical Association Journal. 159 (10): 1245–1252. PMC 1229819. PMID 9861221.
Jarrett, RB; Schaffer, M; McIntire, D; Witt-Browder, A; Kraft, D; Risser, RC (1999). «Treatment of atypical depression with cognitive therapy or phenelzine: A double-blind, placebo-controlled trial». Arch Gen Psychiatry. 56 (5): 431–7. doi:10.1001/archpsyc.56.5.431. PMC 1475805. PMID 10232298.
Mallinger, AG; Frank, E; Thase, ME; Barwell, MM; DiazGranados, N; Luckenbaugh, DA; և այլք: (2009). «Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?». Psychopharmacol Bull. 42 (2): 64–74. PMC 3570273. PMID 19629023.
Heal DJ, Smith SL, Gosden J, Nutt DJ (2013 թ․ հունիս). «Amphetamine, past and present – a pharmacological and clinical perspective». J. Psychopharmacol. 27 (6): 479–96. doi:10.1177/0269881113482532. PMC 3666194. PMID 23539642.
Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D (1996). «St John's wort for depression—an overview and meta-analysis of randomised clinical trials». BMJ. 313 (7052): 253–8. doi:10.1136/bmj.313.7052.253. PMC 2351679. PMID 8704532.
Zhou Z, Zhen J, Karpowich NK, Goetz RM, Law CJ, Reith ME, Wang DN (2007). «LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake». Science. 317 (5843): 1390–3. Bibcode:2007Sci...317.1390Z. doi:10.1126/science.1147614. PMC 3711652. PMID 17690258.
Huber R, Smith K, Delago A, Isaksson K, Kravitz EA (1997). «Serotonin and aggressive motivation in crustaceans: altering the decision to retreat». Proc. Natl. Acad. Sci. U.S.A. 94 (11): 5939–42. Bibcode:1997PNAS...94.5939H. doi:10.1073/pnas.94.11.5939. PMC 20885. PMID 9159179.

nlm.nih.gov

«Bupropion: MedlinePlus Drug Information». Արխիվացված օրիգինալից 2016 թ․ մայիսի 8-ին. Վերցված է 2016 թ․ մայիսի 24-ին.

nytimes.com

Kramer, Peter (2011 թ․ սեպտեմբերի 7). «In Defense of Antidepressants». The New York Times. Արխիվացված օրիգինալից 2011 թ․ հուլիսի 12-ին. Վերցված է 2011 թ․ հուլիսի 13-ին.

pharmacist.com

American Pharmacists Association (2013). «Vortioxetine: Atypical antidepressant». Արխիվացված օրիգինալից 2015 թ․ նոյեմբերի 20-ին.

psychiatrictimes.com

Cristancho, Mario. «Atypical Depression in the 21st Century: Diagnostic and Treatment Issues». Psychiatric Times. Արխիվացված օրիգինալից 2013 թ․ դեկտեմբերի 2-ին. Վերցված է 2013 թ․ նոյեմբերի 23-ին.

psychiatryonline.org

«Practice Guideline for the Treatment of Patients With Major Depressive Disorder» (PDF). PsychiatryOnline (Third ed.).

psychosomaticmedicine.org

Domino EF (1999). «History of modern psychopharmacology: A personal view with an emphasis on antidepressants». Psychosomatic Medicine. 61 (5): 591–8. doi:10.1097/00006842-199909000-00002. PMID 10511010.

qualitywatch.org.uk

Spence, Ruth. «Focus on: Antidepressant prescribing». QualityWatch. QualityWatch (Nuffield Trust/Health Foundation). Արխիվացված օրիգինալից 2015 թ․ փետրվարի 4-ին. Վերցված է 2015 թ․ հունվարի 12-ին.

semanticscholar.org

Andrisano, Costanza; Chiesa, Alberto; Serretti, Alessandro (2013 թ․ հունվար). «Newer antidepressants and panic disorder: a meta-analysis». International Clinical Psychopharmacology. 28 (1): 33–45. doi:10.1097/YIC.0b013e32835a5d2e. ISSN 1473-5857. PMID 23111544.
Ruhé HG, Huyser J, Swinkels JA, Schene AH (2006). «Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder». The Journal of Clinical Psychiatry. 67 (12): 1836–55. doi:10.4088/JCP.v67n1203. PMID 17194261.
Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH (2013). «Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials». The Journal of Clinical Psychiatry. 74 (11): 1101–7. doi:10.4088/JCP.13r08560. PMID 24330897.
Csoka AB, Csoka A, Bahrick A, Mehtonen OP (2008). «Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors». J Sex Med. 5 (1): 227–33. doi:10.1111/j.1743-6109.2007.00630.x. PMID 18173768.
Serretti A, Chiesa A (2009). «Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis». J Clin Psychopharmacol. 29 (3): 259–66. doi:10.1097/JCP.0b013e3181a5233f. PMID 19440080.
Ozmenler NK, Karlidere T, Bozkurt A, Yetkin S, Doruk A, Sutcigil L, Cansever A, Uzun O, Ozgen F, Ozsahin A (2008). «Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors». Hum Psychopharmacol. 23 (4): 321–6. doi:10.1002/hup.929. PMID 18278806.
Rothman RB, Baumann MH, Dersch CM, և այլք: (2001 թ․ հունվար). «Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin». Synapse. 39 (1): 32–41. doi:10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3. PMID 11071707.
Bauer M, Dopfmer S (1999). «Lithium augmentation in treatment-resistant depression: Meta-analysis of placebo-controlled studies». Journal of Clinical Psychopharmacology. 19 (5): 427–34. doi:10.1097/00004714-199910000-00006. PMID 10505584.
Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ (2007 թ․ մարտ). «Lithium treatment reduces suicide risk in recurrent major depressive disorder». J Clin Psychiatry. 68 (3): 380–83. doi:10.4088/JCP.v68n0304. PMID 17388706.
Ecks S (2005). «Pharmaceutical Citizenship: Antidepressant Marketing and the Promise of Demarginalization in India». Anthropology & Medicine. 12 (3): 239–254. doi:10.1080/13648470500291360. PMID 26873669.

smith.edu

science.smith.edu

«Pharmacokinetics of selective serotonin reuptake inhibitors» (PDF). Արխիվացված է օրիգինալից (PDF) 2014 թ․ մայիսի 23-ին.

theguardian.com

Davis, Rowenna (2010 թ․ հունիսի 11). «Antidepressant Use Rises as Recession Feeds Wave of Worry». The Guardian. London. Արխիվացված օրիգինալից 2010 թ․ հունիսի 15-ին. Վերցված է 2010 թ․ հուլիսի 1-ին.

time.com

«Psychic Energizer». Time. 1957 թ․ ապրիլի 15. Արխիվացված է օրիգինալից 2013 թ․ օգոստոսի 11-ին. Վերցված է 2009 թ․ մայիսի 28-ին.

ucsd.edu

toxicology.ucsd.edu

Boyer EW, Shannon M (2005). «The serotonin syndrome» (PDF). N. Engl. J. Med. 352 (11): 1112–20. doi:10.1056/NEJMra041867. PMID 15784664. Արխիվացված է օրիգինալից (PDF) 2013 թ․ հունիսի 18-ին.

vu.edu.au

vuir.vu.edu.au

Cox, Georgina R.; Callahan, Patch; Churchill, Rachel; Hunot, Vivien; Merry, Sally N.; Parker, Alexandra G.; Hetrick, Sarah E. (2014 թ․ նոյեմբերի 30). «Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents» (PDF). The Cochrane Database of Systematic Reviews. 11 (11): CD008324. doi:10.1002/14651858.CD008324.pub3. ISSN 1469-493X. PMID 25433518.

web.archive.org

«Depression in adults: The treatment and management of depression in adults». NICE guidelines [CG90]. National Institute for Health and Care Excellence (UK). 2009 թ․ հոկտեմբեր. Արխիվացված օրիգինալից 2015 թ․ սեպտեմբերի 23-ին. Վերցված է 2015 թ․ սեպտեմբերի 23-ին.
«www.nice.org.uk» (PDF). Արխիվացված է օրիգինալից (PDF) 2012 թ․ հոկտեմբերի 21-ին. Վերցված է 2013 թ․ փետրվարի 20-ին.
«www.nice.org.uk» (PDF). Արխիվացված է օրիգինալից (PDF) 2008 թ․ դեկտեմբերի 6-ին.
«Paroxetine prescribing information» (PDF). Արխիվացված է օրիգինալից (PDF) 2015 թ․ փետրվարի 19-ին. Վերցված է 2015 թ․ հունվարի 30-ին.
«Sertraline prescribing information» (PDF). Արխիվացված (PDF) օրիգինալից 2015 թ․ հունիսի 16-ին. Վերցված է 2015 թ․ հունվարի 30-ին.
«www.nice.org.uk» (PDF). Արխիվացված (PDF) օրիգինալից 2014 թ․ մարտի 27-ին.
«Bupropion: MedlinePlus Drug Information». Արխիվացված օրիգինալից 2016 թ․ մայիսի 8-ին. Վերցված է 2016 թ․ մայիսի 24-ին.
«National Guideline Clearinghouse | Practice guideline for the treatment of patients with eating disorders». 2018 թ․ հուլիսի 5. Արխիվացված է օրիգինալից 2013 թ․ մայիսի 25-ին.
«www.enfa-europe.eu» (PDF). Արխիվացված է օրիգինալից (PDF) 2014 թ․ մայիսի 23-ին.
«Antidepressant Use in Persons Aged 12 and Over: United States, 2005–2008». cdc.gov. Products – Data Briefs – Number 76 – October 2011. Centers for Disease Control and Prevention. Արխիվացված օրիգինալից 2016 թ․ փետրվարի 4-ին. Վերցված է 2016 թ․ փետրվարի 4-ին.
Boyer EW, Shannon M (2005). «The serotonin syndrome» (PDF). N. Engl. J. Med. 352 (11): 1112–20. doi:10.1056/NEJMra041867. PMID 15784664. Արխիվացված է օրիգինալից (PDF) 2013 թ․ հունիսի 18-ին.
«FDA Advising of Risk of Birth Defects with Paxil» (Press release). U.S. Food and Drug Administration. Արխիվացված է օրիգինալից 2013 թ․ դեկտեմբերի 3-ին. Վերցված է 2012 թ․ նոյեմբերի 29-ին.
Sivagnanam, G (2012). «Antidepressants». Journal of Pharmacology and Pharmacotherapeutics. 3 (3): 287–8. Արխիվացված է օրիգինալից 2018 թ․ հուլիսի 1-ին. Վերցված է 2022 թ․ մայիսի 18-ին.
«FDA Medication Guide for Antidepressants». Արխիվացված օրիգինալից 2014 թ․ օգոստոսի 18-ին. Վերցված է 2014 թ․ հունիսի 5-ին.
«Antidepressant Use in Children, Adolescents, and Adults». Արխիվացված օրիգինալից 2016 թ․ դեկտեմբերի 19-ին.
«www.nice.org.uk» (PDF). Արխիվացված (PDF) օրիգինալից 2012 թ․ հոկտեմբերի 18-ին.
Healy D, Aldred G (2005). «Antidepressant drug use and the risk of suicide» (PDF). International Review of Psychiatry. 17 (3): 163–172. doi:10.1080/09540260500071624. PMID 16194787. Արխիվացված է օրիգինալից (PDF) 2013 թ․ հոկտեմբերի 21-ին.
Stimmel GL, Dopheide JA, Stahl SM (1997). «Mirtazapine: An antidepressant with noradrenergic and specific serotonergic effects». Pharmacotherapy. 17 (1): 10–21. doi:10.1002/j.1875-9114.1997.tb03674.x (inactive 2020 թ․ հունվարի 16). PMID 9017762. Արխիվացված է օրիգինալից 2021 թ․ մայիսի 25-ին. Վերցված է 2020 թ․ հունվարի 28-ին.{{cite journal}}: CS1 սպաս․ DOI inactive as of 2020 (link)
«mirtazapine (Rx) – Remeron, Remeron SolTab». Medscape. WebMD. Արխիվացված է օրիգինալից 2013 թ․ հոկտեմբերի 29-ին. Վերցված է 2013 թ․ նոյեմբերի 19-ին.
«Effexor Medicines Data Sheet». Wyeth Pharmaceuticals Inc. 2006. Արխիվացված է օրիգինալից 2006 թ․ սեպտեմբերի 17-ին. Վերցված է 2006 թ․ սեպտեմբերի 17-ին.
Kramer, Peter (2011 թ․ սեպտեմբերի 7). «In Defense of Antidepressants». The New York Times. Արխիվացված օրիգինալից 2011 թ․ հուլիսի 12-ին. Վերցված է 2011 թ․ հուլիսի 13-ին.
American Pharmacists Association (2013). «Vortioxetine: Atypical antidepressant». Արխիվացված օրիգինալից 2015 թ․ նոյեմբերի 20-ին.
Los Angeles Times (2013). «FDA approves a new antidepressant: Brintellix». Արխիվացված օրիգինալից 2015 թ․ նոյեմբերի 20-ին.
Cristancho, Mario. «Atypical Depression in the 21st Century: Diagnostic and Treatment Issues». Psychiatric Times. Արխիվացված օրիգինալից 2013 թ․ դեկտեմբերի 2-ին. Վերցված է 2013 թ․ նոյեմբերի 23-ին.
«Depressive Disorders». Merck Manual. Արխիվացված է օրիգինալից 2013 թ․ դեկտեմբերի 5-ին. Վերցված է 2012 թ․ նոյեմբերի 30-ին.
«Psychic Energizer». Time. 1957 թ․ ապրիլի 15. Արխիվացված է օրիգինալից 2013 թ․ օգոստոսի 11-ին. Վերցված է 2009 թ․ մայիսի 28-ին.
«Tranquilizers». Cumberland Mountain Community Services. cmcsb.com. Արխիվացված է օրիգինալից 2012 թ․ սեպտեմբերի 16-ին. Վերցված է 2013 թ․ նոյեմբերի 20-ին.Կաղապար:Unreliable medical source
Wong DT, Bymaster FP, Horng JS, Molloy BB (1975). «A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine». The Journal of Pharmacology and Experimental Therapeutics. 193 (3): 804–11. PMID 1151730. Արխիվացված է օրիգինալից 2021 թ․ նոյեմբերի 19-ին. Վերցված է 2020 թ․ հունվարի 30-ին.
White, Rebecca. «Waking up from sadness: Many find trouble getting off antidepressants». Al Jazeera. Արխիվացված օրիգինալից 2014 թ․ հուլիսի 14-ին. Վերցված է 2014 թ․ հունիսի 8-ին.
Davis, Rowenna (2010 թ․ հունիսի 11). «Antidepressant Use Rises as Recession Feeds Wave of Worry». The Guardian. London. Արխիվացված օրիգինալից 2010 թ․ հունիսի 15-ին. Վերցված է 2010 թ․ հուլիսի 1-ին.
Spence, Ruth. «Focus on: Antidepressant prescribing». QualityWatch. QualityWatch (Nuffield Trust/Health Foundation). Արխիվացված օրիգինալից 2015 թ․ փետրվարի 4-ին. Վերցված է 2015 թ․ հունվարի 12-ին.
«Top 200 generic drugs by units in 2010» (PDF). Արխիվացված է օրիգինալից (PDF) 2012 թ․ դեկտեմբերի 15-ին.«Top 200 brand drugs by units in 2010» (PDF). Արխիվացված է օրիգինալից (PDF) 2012 թ․ ապրիլի 22-ին.
«GIPdatabank». Gipdatabank.nl. Արխիվացված է օրիգինալից 2008 թ․ դեկտեմբերի 6-ին. Վերցված է 2008 թ․ նոյեմբերի 6-ին.
«Pharmacokinetics of selective serotonin reuptake inhibitors» (PDF). Արխիվացված է օրիգինալից (PDF) 2014 թ․ մայիսի 23-ին.

webmd.com

Allen, Arthur. «Coping With Side Effects of Depression Treatment». WebMD. Վերցված է 2019 թ․ փետրվարի 4-ին.

websitetestlink.com

davidhealy.org.php53-23.dfw1-1.websitetestlink.com

Healy D, Aldred G (2005). «Antidepressant drug use and the risk of suicide» (PDF). International Review of Psychiatry. 17 (3): 163–172. doi:10.1080/09540260500071624. PMID 16194787. Արխիվացված է օրիգինալից (PDF) 2013 թ․ հոկտեմբերի 21-ին.

who.int

«Adherence to Long Term Therapies: Evidence for Action» (PDF). World Health Organization. 2003.

wiley.com

accpjournals.onlinelibrary.wiley.com

Stimmel GL, Dopheide JA, Stahl SM (1997). «Mirtazapine: An antidepressant with noradrenergic and specific serotonergic effects». Pharmacotherapy. 17 (1): 10–21. doi:10.1002/j.1875-9114.1997.tb03674.x (inactive 2020 թ․ հունվարի 16). PMID 9017762. Արխիվացված է օրիգինալից 2021 թ․ մայիսի 25-ին. Վերցված է 2020 թ․ հունվարի 28-ին.{{cite journal}}: CS1 սպաս․ DOI inactive as of 2020 (link)

worldcat.org

Cipriani, Andrea; Furukawa, Toshi A; Salanti, Georgia; Chaimani, Anna; Atkinson, Lauren Z; Ogawa, Yusuke; Leucht, Stefan; Ruhe, Henricus G; Turner, Erick H; Higgins, Julian P T; Egger, Matthias; Takeshima, Nozomi; Hayasaka, Yu; Imai, Hissei; Shinohara, Kiyomi; Tajika, Aran; Ioannidis, John P A; Geddes, John R (2018). «Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». The Lancet. 391 (10128): 1357–1366. doi:10.1016/S0140-6736(17)32802-7. ISSN 0140-6736. PMC 5889788. PMID 29477251.
Barth, Michael; Kriston, Levente; Klostermann, Swaantje; Barbui, Corrado; Cipriani, Andrea; Linde, Klaus (2018). «Efficacy of selective serotonin reuptake inhibitors and adverse events: Meta-regression and mediation analysis of placebo-controlled trials». British Journal of Psychiatry. 208 (2): 114–119. doi:10.1192/bjp.bp.114.150136. ISSN 0007-1250. PMID 26834168.
Cipriani, Andrea; Zhou, Xinyu; Del Giovane, Cinzia; Hetrick, Sarah E; Qin, Bin; Whittington, Craig; Coghill, David; Zhang, Yuqing; Hazell, Philip; Leucht, Stefan; Cuijpers, Pim; Pu, Juncai; Cohen, David; Ravindran, Arun V; Liu, Yiyun; Michael, Kurt D; Yang, Lining; Liu, Lanxiang; Xie, Peng (2016). «Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis». The Lancet. 388 (10047): 881–890. doi:10.1016/S0140-6736(16)30385-3. ISSN 0140-6736. PMID 27289172. «When considering the risk-benefit profile of antidepressants in the acute treatment of major depressive disorder, these drugs do not seem to offer a clear advantage for children and adolescents.»
Turner, Erick H; Rosenthal, Robert (2008). «Efficacy of antidepressants». BMJ. 336 (7643): 516–517. doi:10.1136/bmj.39510.531597.80. ISSN 0959-8138. PMC 2265347. PMID 18319297.
Kirsch, Irving (2014). «Antidepressants and the Placebo Effect». Zeitschrift für Psychologie. 222 (3): 128–134. doi:10.1027/2151-2604/a000176. ISSN 2190-8370. PMC 4172306. PMID 25279271.
Hansen, Richard A.; Gaynes, Bradley N.; Gartlehner, Gerald; Moore, Charity G.; Tiwari, Ruchi; Lohr, Kathleen N. (2008 թ․ մայիս). «Efficacy and Tolerability of Second-Generation Antidepressants in Social Anxiety Disorder». International Clinical Psychopharmacology. 23 (3): 170–179. doi:10.1097/YIC.0b013e3282f4224a. ISSN 0268-1315. PMC 2657552. PMID 18408531.
Canton, John; Scott, Kate M; Glue, Paul (2012). «Optimal treatment of social phobia: systematic review and meta-analysis». Neuropsychiatric Disease and Treatment. 8: 203–215. doi:10.2147/NDT.S23317. ISSN 1176-6328. PMC 3363138. PMID 22665997.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Kellner, Michael (2010 թ․ հունիս). «Drug treatment of obsessive-compulsive disorder». Dialogues in Clinical Neuroscience. 12 (2): 187–197. ISSN 1294-8322. PMC 3181958. PMID 20623923.
Alexander, Walter (2012 թ․ հունվար). «Pharmacotherapy for Post-traumatic Stress Disorder In Combat Veterans». Pharmacy and Therapeutics. 37 (1): 32–38. ISSN 1052-1372. PMC 3278188. PMID 22346334.
Bighelli, Irene; Castellazzi, Mariasole; Cipriani, Andrea; Girlanda, Francesca; Guaiana, Giuseppe; Koesters, Markus; Turrini, Giulia; Furukawa, Toshi A.; Barbui, Corrado (2018 թ․ ապրիլի 5). «Antidepressants versus placebo for panic disorder in adults». The Cochrane Database of Systematic Reviews. 4: CD010676. doi:10.1002/14651858.CD010676.pub2. ISSN 1469-493X. PMC 6494573. PMID 29620793.
Andrisano, Costanza; Chiesa, Alberto; Serretti, Alessandro (2013 թ․ հունվար). «Newer antidepressants and panic disorder: a meta-analysis». International Clinical Psychopharmacology. 28 (1): 33–45. doi:10.1097/YIC.0b013e32835a5d2e. ISSN 1473-5857. PMID 23111544.
Bighelli, Irene; Trespidi, Carlotta; Castellazzi, Mariasole; Cipriani, Andrea; Furukawa, Toshi A.; Girlanda, Francesca; Guaiana, Giuseppe; Koesters, Markus; Barbui, Corrado (2016 թ․ սեպտեմբերի 12). «Antidepressants and benzodiazepines for panic disorder in adults». The Cochrane Database of Systematic Reviews. 9: CD011567. doi:10.1002/14651858.CD011567.pub2. ISSN 1469-493X. PMC 6457579. PMID 27618521.
Moore, R. Andrew; Derry, Sheena; Aldington, Dominic; Cole, Peter; Wiffen, Philip J. (2015 թ․ հուլիսի 6). «Amitriptyline for neuropathic pain in adults». The Cochrane Database of Systematic Reviews (7): CD008242. doi:10.1002/14651858.CD008242.pub3. ISSN 1469-493X. PMC 6447238. PMID 26146793.
Agabio, Roberta; Trogu, Emanuela; Pani, Pier Paolo (2018). «Antidepressants for the treatment of people with co-occurring depression and alcohol dependence». The Cochrane Database of Systematic Reviews. 4: CD008581. doi:10.1002/14651858.CD008581.pub2. ISSN 1469-493X. PMC 6494437. PMID 29688573.
Richards, Bethan L; Whittle, Samuel L; Buchbinder, Rachelle (2011 թ․ նոյեմբերի 9). «Antidepressants for pain management in rheumatoid arthritis». Cochrane Database of Systematic Reviews (11): CD008920. doi:10.1002/14651858.cd008920.pub2. ISSN 1465-1858. PMID 22071859.
Salvi, Virginio; Grua, Ilaria; Cerveri, Giancarlo; Mencacci, Claudio; Barone-Adesi, Francesco (2017 թ․ հուլիսի 31). Meyre, David (ed.). Կաղապար:CC-PMC. «The risk of new-onset diabetes in antidepressant users – A systematic review and meta-analysis». PLOS ONE. Public Library of Science (PLoS). 12 (7): e0182088. Bibcode:2017PLoSO..1282088S. doi:10.1371/journal.pone.0182088. ISSN 1932-6203. PMC 5536271. PMID 28759599. «In our meta-analysis we found an association between exposure to ADs and new-onset diabetes, with a relative risk of 1.27. When we restricted the analysis to the studies to high NOS score the association between ADs and diabetes was even stronger. The results are in line with those from two previous meta-analyses that reported a 1.5-fold increase of diabetes among AD users.»{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Cox, Georgina R.; Callahan, Patch; Churchill, Rachel; Hunot, Vivien; Merry, Sally N.; Parker, Alexandra G.; Hetrick, Sarah E. (2014 թ․ նոյեմբերի 30). «Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents» (PDF). The Cochrane Database of Systematic Reviews. 11 (11): CD008324. doi:10.1002/14651858.CD008324.pub3. ISSN 1469-493X. PMID 25433518.

wyeth.com

«Effexor Medicines Data Sheet». Wyeth Pharmaceuticals Inc. 2006. Արխիվացված է օրիգինալից 2006 թ․ սեպտեմբերի 17-ին. Վերցված է 2006 թ․ սեպտեմբերի 17-ին.

zenodo.org

Pies R (2010 թ․ ապրիլ). «Antidepressants Work, Sort of-Our System of Care Does Not». Journal of Clinical Psychopharmacology. 30 (2): 101–104. doi:10.1097/JCP.0b013e3181d52dea. PMID 20520282.
Pies, Ronald W. (2016). «Antidepressants». Journal of Clinical Psychopharmacology. 36 (1): 1–4. doi:10.1097/jcp.0000000000000455. PMID 26658086.